****Sponsored by Sideways Frequency, LLC

‍

‍

Qualigen to participate in next funding round for NanoSynex

QLGN has closed green 8 of the last 10

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft(TM)

Qualigen sold its FastPack^® diagnostics business to Chembio Diagnostics, Inc in 2023 for roughly $5 Million

CHECK OUT THE INVESTOR PRESENTATION HERE

_________________________

Hello Everyone,

We are seeing some pain in the markets given the current situation with tariffs and economic uncertainty around the world. The Nasdaq has taken a sizeable dip since February and the Dow is down significantly from its highs in January. However, we always say that there are opportunities in any market that can deliver. All you have to do is look at the 5,10,20 year charts and you can come to the conclusion that this is temporary. Here is a little fun fact for you that I am sure you are not aware of; Since 1957, the S&P 500 has hit a new record high on average about every 14 trading days. Sounds like a long term strategy that can’t lose baring a cataclysmic event.

We know that the market will be back in Bull Mode eventually, we just don’t know when.

Let’s take a look at a company that has been bucking the trend lately.

Pull up QLGN and let’s get it on your radar for Monday’s session.

QLGN has some momentum behind it right now and has closed green 8 of the last 10.

What is interesting about the momentum and the roughly 30% move over the past 2 weeks is that it seems to be occurring organically with no recent news pushing this one north.

Qualigen Therapeutics, Inc. is an early-clinical-stage biotechnology company. Until the sale of its diagnostic business in 2023 when Qualigen sold its FastPack^® diagnostics business to Chembio Diagnostics, Inc., an American subsidiary of French diagnostics provider BIOSYNEX Group, a leader in the design and distribution of rapid tests, Qualigen had a 20+ year history developing, marketing and selling medical devices in the United States and internationally. Their investigational QN-302 compound is a small molecule selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells; such binding could, by stabilizing the G4s against “unwinding,” help inhibit cancer cell proliferation. QN-302 is currently in a Phase 1a clinical trial. The preclinical compounds within Qualigen’s family of Pan-RAS oncogene protein-protein interaction inhibitor small molecules are believed to inhibit or block the binding of mutated RAS genes’ proteins to their effector proteins, thereby leaving the proteins from the mutated RAS unable to cause further harm. In theory, such mechanism of action may be effective in the treatment of about one quarter of all cancers, including certain forms of pancreatic, colorectal, and lung cancers.

QLGN is working with prominent investigators at University College London and the University of Louisville.

QLGN says it’s lead compound, QN-302, is “a small molecule selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.”

It notes that “such binding could, by stabilizing the G4s against ‘unwinding,’ help inhibit cancer cell proliferation.”

The compound has received arom the FDA for the intended indication of pancreatic cancer

QLGN has concluded that “Mice treated with QN-302 have shown longer survival duration and greater tumor shrinkage in pancreatic cancer in vivo xenograft and genetic models vs. historically standard of care gemcitabine.”

Right now, the company is putting QN-302 through a Phase 1 trial for treatment of advanced or metastatic solid tumors, and it has initially dosed four patients.

The company has done posters, publications, and presentations at 2022, 2023, and 2024 annual and special meetings of the American Association for Cancer Research (AACR).

QLGN’s other major candidate is its Pan-RAS Inhibitor Platform.

The compathat “RAS is the most common cancer oncogene [a mutated gene that can cause cancer], present in more than 30% of all cancers”

QLGN has a family of investigational compounds that “are believed to inhibit or block the binding of mutated RAS genes’ proteins to their effector proteins.”

‍

PIPELINE

About QN-302

QN-302, a novel tetra-substituted naphthalene diimide derivative invented and initially developed at University College London, is a potent binder to quadruplex (G4) sequences in the promoters of cancer genes, with 1-2 nM anti-proliferative activity in human pancreatic cancer (PDAC) cell lines. QN-302 has significant anti-tumor activity in xenograft, orthotopic and genetic (KPC) models of PDAC and retains high activity in gemcitabine-resistant PDAC cell lines. The drug is bio-available and well tolerated at therapeutic doses in the various animal models.

QN-302 is being developed by Qualigen Therapeutics Inc. It was granted Orphan Drug status for Pancreatic Ductal Adenocarcinoma (PDAC) by the FDA in January 2023 and granted Investigational New Drug (IND) clearance in August 2023 by the FDA for phase 1 clinical trial in advanced or metastatic solid tumors. This trial is being conducted at two cancer centers in the USA. In this first-in-human Phase 1 dose-finding study, the study design is for QN-302 to be given once a week, intravenously over 60 min, on Day 1, Day 8, and Day 15 of a 28-Day cycle. The study is designed to use a standard oncology 3+3 dose escalation design, with enrollment of 3 patients per cohort and expansion to 6 patients in the event of a DLT (Dose Limiting Toxicity). Five patients have been enrolled to date in the trial, two with colorectal adenocarcinoma as their primary cancer. Both were subsequently withdrawn from the trial, due to non-QN-302 issues (Grade 2 anemia: disease progression). One completed one cycle of QN-302 with no serious adverse effects (SAE).

Qualigen to participate in next funding round for NanoSynex

Market size expected to reach $4.7 billion in 2027

CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”)announced today they will be the first investors participating in the 2025 bridge round of funding for NanoSynex. NanoSynex will be raising up to $500,000.

“We are very excited to participate and be the first investors to commit in this round of funding for NanoSynex. The technology they are developing will help the world of Antimicrobial Susceptibility Testing (AST) by reducing the time required for tests in half, offering more robust diagnostics, which will lead to better use and not over use of the wrong antibiotics for patients globally. The Minimum Viable Product (MVP) System has numerous competitive advantages to existing tests and is priced competitively with those slower and less robust products.”, stated Kevin Richardson II, CEO of Qualigen. NanoSynex plans to be approved for the EU market in 2027 and US in 2028. The market size globally is expected to reach $4.7 billion by 2027. The US market alone is expected to reach $1.6 billion. NaoSynex also has a strong pipeline of other indications and verticals they can pursue with this technology. NanoSynex also has 4 patents protecting the technology.

Diane Abensur, CEO of NanoSynex, stated, “We are thrilled to have Qualigen’s involvement in being the first to commit to this bridge round funding. It will allow us to jump start our product development of our MVP system for AST, generation 2.0 . The need for our product and the lives we can help save by getting more timely and accurate robust diagnostics will help NanoSynex grow dramatically.”

ABOUT NANOSYNEX

NanoSynex is a MedTech company, based in Israel, that aims at providing new solutions to improve testing quality and reduce healthcare costs by speeding up diagnostic processes.

Today, NanoSynex is focused on the development and commercialization of a rapid innovative Antimicrobial Susceptibility Test (AST). The technology is based on a purely phenotypic approach and uses a microfluidic disposable test card platform and method that optimizes bacterial growth. This disruptive development was born from exciting research discoveries at the lab of Professor Shulamit Levenberg, former Dean of the Technion Institute of Technology – Biomedical Engineering Faculty.

NanoSynex’s team is composed of passionate, dedicated business executives, top-notch biomedical engineers and microbiologist team members and supported by a network of experts, including strategic alliances with future distributors, that know how to bring this revolutionary product to the market.

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft(TM)

JUPITER, FL, April 16, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Marizyme, Inc. (“Marizyme”, OTCQB: MRZM) announces today a Co-Development Agreement (the “Agreement”) with Qualigen Therapeutics, Inc. (“Qualigen”) (NASDAQ:QLGN ) to advance the commercialization of Marizyme’s first-in-class FDA cleared product, DuraGraft™.

DuraGraft™ was granted a De Novo – FDA Clearance on October 4, 2023, from the U.S. Food and Drug Administration (FDA).  DuraGraft™ is labeled for use as a vascular conduit solution indicated for adult patients undergoing Coronary Artery Bypass Grafting (CABG) surgeries and is intended for the flushing and storage of the saphenous vein grafts used in CABG surgery. According to the Society of Thoracic Surgeons, there are over 500,000 CABG procedures performed annually in the U.S., representing a major market for this commercial-ready product.

Pursuant to the Agreement, Qualigen will help support the commercial launch in the United States of DuraGraft™, including post-clearance clinical studies to advance the use of DuraGraft™ in the U.S., by providing up to $1.5 million in funding over the next several months for these purposes.  In return, Qualigen will receive a share of Marizyme’s gross profit on future U.S. sales of the product, capped at a 2X return on Qualigen’s invested capital. Qualigen has also purchased an exclusive negotiation period ending May 31, 2024, for purposes of proposing and outlining a broader strategic relationship between the two companies.

David Barthel, CEO of Marizyme, stated: “This is an exciting opportunity for Marizyme to accelerate the commercialization of DuraGraft™.  In addition to the non-dilutive funding that Qualigen will provide, we believe strongly in the importance of this technology and commercial potential for DuraGraft™ in the United States, and look forward to building this strategic relationship.”

Michael Poirier, CEO of Qualigen, stated: “We are thrilled to be supporting the Marizyme team.  This agreement provides Qualigen with participation in an FDA-cleared commercialization project with a visible path to revenue generation in the short term.  It also allows us the flexibility to broaden this relationship over the next four months.”

About Marizyme

Marizyme, Inc. is a medical technology company changing the landscape of cardiac care by delivering innovative solutions for coronary artery bypass graft (CABG) surgery. Marizyme’s first in-class product, DuraGraft™, was granted a de novo clearance on October 4, 2023, from the U.S. Food and Drug Administration (FDA). DuraGraft™, with its CE Mark, continues to drive sales growth for Marizyme internationally in Europe and Asia, and will now target the U.S. market to drive further utilization and sales.

NEWS

‍
Qualigen to participate in next funding round for NanoSynex

Jan 28, 2025

Qualigen Therapeutics Announces Regained Compliance with Nasdaq’s Minimum Bid Price Requirement and the Equity Requirement

Dec 5, 2024

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Nov 25, 2024

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares

Nov 19, 2024

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024

Nov 1, 2024

Qualigen Therapeutics, Inc. Announces management changes.

Sep 26, 2024

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel

Sep 20, 2024

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Sep 6, 2024

Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering

Sep 6, 2024

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering

Sep 5, 2024

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination

May 30, 2024

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft(TM)

Apr 16, 2024

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™

Apr 16, 2024

Qualigen Therapeutics’ Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting

Apr 10, 2024

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting

Apr 9, 2024

MANAGEMENT

Michael Poirier

CEO and Chairman

Michael S. Poirier founded Qualigen in 1996 and is its Chairman and Chief Executive Officer. Prior to founding Qualigen, Mr. Poirier was Vice President of Marketing for Ashirus Technologies, Inc., a Minneapolis-based manufacturer of innovative high-precision dispensing pumps and related equipment for the medical industry. From 1993 to 1995, Mr. Poirier was Director of US Area Operations for EnSys, Inc., located in Research Triangle, North Carolina. EnSys developed and manufactured field-portable immunoassay test kits for the environmental remediation industry. From 1991 to 1993, Mr. Poirier was employed by Sanofi Pasteur in Chaska, Minnesota, as a Marketing Manager responsible for launching the ACCESS^® Immunoassay System. This novel diagnostic system was later acquired by Beckman-Coulter and is now one of the leading immunoassay test systems worldwide. From 1985 to 1991, Mr. Poirier was employed by Abbott Diagnostics, a division of Abbott Laboratories, Inc. in various marketing and sales positions, including Worldwide Immunoassay Product Manager for the IMx^® and AxSym^® immunoassay diagnostic systems. Both IMx and later, AxSym, became the leaders in their respective markets. Prior to working at Abbott, Mr. Poirier served as an officer in the United States Navy, assigned to the US Atlantic Fleet. Mr. Poirier holds a B.A. from Providence College and attended the University of Zürich, Switzerland, School of Law.

Wajdi Abdul-Ahad, PhD

Vice President, R&D, Chief Scientific Officer

Dr. Abdul-Ahad is Qualigen’s Vice President of Research and Development and Chief Scientific Officer. Since joining the Company in 2006, he has successfully developed and commercialized numerous complex immunoassays on both the FastPack and FastPack IP Systems. In addition, Dr. Abdul-Ahad is responsible for all surface coating, nanotechnology and reagent manufacturing, as well as integration of new drug manufacturing systems and processes. Prior to joining Qualigen, Dr. Abdul-Ahad led multifunctional design teams at Beckman Coulter that developed and commercialized over 15 assays on their industry leading Access and Synchron automated systems. From 1988 to 1990, Dr. Abdul-Ahad held various management positions with the National Diagnostics Center and Noctech, Inc., both located in Galway, Ireland. Dr. Abdul-Ahad holds a PhD in Biochemistry from National University of Ireland, Galway; an MS in Clinical Chemistry from the University of Surrey, England; an MBA from the University of La Verne, California and a BS in Pharmacy from the University of Baghdad, Iraq. He also holds certifications and licenses from the American Board of Clinical Chemistry, State of California (Registered Pharmacist), National Registry of Clinical Chemistry and the National Academy for Clinical Biochemistry. Dr. Abdul-Ahad’s professional affiliations include the Association of Clinical Biochemistry (ACB-UK), the American Association for Clinical Chemistry and the American Pharmaceutical Association. Dr. Abdul-Ahad is also the author or co-author of numerous scientific publications.

Tariq Arshad MD, MBA

Senior Vice President, Chief Medical Officer

Dr. Arshad brings more than 20 years of biotech and pharmaceutical experience to Qualigen Therapeutics. He is an oncologist with expertise in both early and late stage clinical development at several leading and emergent biopharmaceutical companies, including leadership roles at Becton Dickinson, Sanofi Genzyme, Humanigen, XOMA, Merck, Genentech, and Pfizer. Dr. Arshad was Global Head of Medical Affairs and Clinical Research for Becton Dickinson BioSciences in San Jose, California where he lead a team of MDs and PHDs driving scientific strategy for a cutting-edge immuno-oncology focused portfolio.

Amy S. Broidrick

President and Chief Strategy Officer, Director

Ms. Broidrick has over 26 years experience in the biopharmaceutical industry in a variety of functions and increasing responsibility. Ms. Broidrick served from 2016 to 2020 as Senior Vice President, Global Head of Corporate Development of Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company where she was responsible for building and implementing the US and global corporate and business development functions. Before that, she was Vice President, Head of Global Marketing Excellence and Business Innovation with EMD Serono (part of Merck KGaA). Earlier, she was Vice President, Head of Marketing and Commercialization at Arena Pharmaceuticals, Inc., and held roles of increasing responsibility at Merck & Co. and Pfizer (formerly GD Searle) including Global Brand Leader with worldwide P&L accountability. Ms. Broidrick holds a BA from Fairleigh Dickinson University, completed further undergraduate studies at Wroxton College in England, and performed post-graduate work at Fairleigh Dickinson.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SIX THOUSAND FIVE HUNDRED USD BY SIDEWAYS FREQUENCY LLC FOR A ONE DAY QLGN AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

****Sponsored by LFG Equities Corp.

Smartkem Signs MOU with RiTdisplay to Integrate Smartkem’s OTFT Process Onto Its Gen2.5 Line – creating the first commercial OTFT prototyping line for next generation AMOLED displays

Smartkem To Unveil First MicroLED-in-a-Package (MiP) Backlight Demonstration at Touch Taiwan 2025

Smartkem Partners with AUO to develop the world’s first rollable, transparent MicroLED display – the first display in production using Smartkem’s technology

Smartkem Completes First Sale of its TRUFLEX® Semiconductor Materials to Chip Foundation under their Co-Development Agreement

Smartkem Receives $1.1M Grant from Innovate UK for Advanced MicroLED Displays

SMTK has entered into multiple strategic collaborations and agreements with industry-leading display manufacturers in Asia, North America, and Europe

READ THE INVESTOR PRESENTATION HERE

‍

_________________________

‍

Hello Everyone,

Yesterday was an exciting day for our members. We knew that we needed to bounce back strong after that previous profile that went south on us.

I know that 2025 is off to a great start with countless double and triple digit winners but we don’t have a crystal ball here. Every once in a while this happens but it’s al all about the bounce back.

I would say we bounced back pretty strong with our last profile closing Monday night at 1.03 and then breaching 1.50 mark during the session on Tuesday. It was a tremendous move!

Moving on we have a past profile back on deck right now that you will surely remember if you have been a member of our email list for a few months.

Does SMTK ring a bell?

It should because it was one of our biggest profiles of 2024.

We brought this one to your attention back in late November where we saw it open up at $3.91 on heavy interest. It closed that session at 5.72 then made new highs in the after hours when it broke 6 bucks.

The next morning it hit $10.95 in the premarket for a potential 180% move.

We want you to research SMTK again as it sits at the same levels as our previous profile price.

Smartkem is seeking to reshape the world of electronics with its disruptive organic thin-film transistors (OTFTs) that have the potential to revolutionize the display industry.  

In seeking to enable the adoption and mass commercialization of next generation MicroLED displays, Smartkem’s low temperature (80°C) process allows its liquid transistors to be poured directly onto the MicroLEDs, eliminating many of the high-cost, low-yield manufacturing processes used in traditional production.

This innovation reduces defects, enhances yield and integrates seamlessly into existing manufacturing processes, making MicroLED displays more commercially viable across sectors including smartphones, wearables, automotives and digital signage.

Smartkem develops its materials at its research and development facility in Manchester, UK and provides prototyping services at the Centre for Process Innovation (CPI) at Sedgefield, UK. It has a field application office in Taiwan. The company has an extensive IP portfolio including 138 granted patents across 17 patent families, 16 pending patents and 40 codified trade secrets.

‍

SMTK has entered into a number of joint agreements with outside companies, including:

• February 2024: Shanghai-based Tianma Microelectronics “to integrate Smartkem’s Organic Thin-Film Transistor (OTFT) technology with Tianma’s oxide transistors to develop OTFT-based microarray biochips.”

• March 2024: Taiwan-based RiTdisplay “for the manufacture of a new type of active-matrix OLED (AMOLED) display.”
• March 2024: The Industrial Technology Research Institute (ITRI) in Taiwan to enable customers access to product prototyping on its Gen2.5 line using Smartkem’s OTFT technology.

• September 2024: Shanghai-based Chip Foundation “to co-develop a new generation of microLED-based backlight technology for Liquid Crystal Displays.”
• November 2024: Smartkem and AUO Partner to Develop a New Generation of Rollable, Transparent MicroLED Displays
• December 2024: Smartkem Signs Multi-Year Agreement with FlexiIC to Develop a New Generation of CMOS for Smart Sensors
• March 2025: Signed MOU with RiTdisplay to Integrate Smartkem’s OTFT process onto its Gen2.5 Line to commercialize the next generation of AMOLED displays using OTFT technology

Dr. Maosheng Hao, chairman of Chip Foundation, said:

“Smartkem is widely recognized as a leading provider of OTFT solutions, with deep expertise and extensive experience in organic dielectric materials, organic semiconductor materials, and related processes. ….

“We believe that this collaboration between our two companies has the potential to expedite the advancement and widespread adoption of this technology by the display industry.”

Those are just a few key agreements. If you check out the companies website and news feed you are going to find several more.

Using its TRUFLEX® organic semiconductor and dielectric inks, or liquid polymers, Smartkem has developed a complete six-layer transistor stack and fabrication process. Smartkem’s core chemistry enables its electronic polymers to be processed at temperatures as low as 80^oC, which by electronic industry standards is very low. The inks are solution deposited, onto low-cost plastic or glass substrates.

Breakthrough Technology

The TRUFLEX® materials stack is a breakthrough technology comprising six individually designed material formulations encompassing every layer in the device, starting from the initial planarising base layer, all the way through to the final passivation layer chemistry. The ink set includes the active organic semiconductor material and a series of orthogonal passive interlayer inks (Base layer, Self-Assembled Monolayer, Organic Gate Insulator, Sputter Resistant Layer and Passivation layer). Smartkem’s proprietary materials set is covered by an extensive IP portfolio comprising 125 granted patents across 19 patent families and 40 codified trade secrets.

Recent Accomplishments

• AUO to jointly develop the world’s first advanced rollable, transparent microLED display;
• FlexiIC to develop low-cost, rapid turnaround custom circuits using organic transistor technology and a new generation of low-power CMOS-enabled smart sensor devices;
• ITRI (Industrial Technology Research Institute) to enable product prototyping on its Gen 2.5 equipment;
• Chip Foundation to co-develop a new generation of microLED-based backlight technology for Liquid Crystal Displays;
• Shanghai Tianma Microelectronics to develop OTFT-based microarray biochips to amplify and process signals generated by TFT-based sensor devices; and
• An MOU with RiTdisplay to manufacture a new type of active-matrix OLED display and integrate Smartkem’s OTFT process on its Gen2.5 line for product commercialization
• Increased IP to 138 patents and 40 codified trade secrets, strengthening Smartkem’s competitive advantage in the rapidly evolving organic materials electronics industry.
• Uplisted to Nasdaq.
• Awarded a grant in partnership with AUO from the 2024 Taiwan-UK Research & Development Collaboration.
• Exhibited and presented at key trade events, including Touch Taiwan 2024 and Display Week 2024 in San Jose, where CEO Ian Jenks gave the DSCC / SID Business Conference keynote speech.

‍

Smartkem Completes First Sale of its TRUFLEX® Semiconductor Materials to Chip Foundation under their Co-Development Agreement

PUBLISHED

JAN 16, 2025 7:05AM EST

Sales under the Chip Foundation co-development agreement are expected to continue throughout 2025

MANCHESTER, England, Jan. 16, 2025 /PRNewswire/ — Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics using its disruptive organic thin-film transistors (OTFTs), announced that it has completed the first sale of its TRUFLEX® semiconductor materials to its joint development partner, Shanghai Chip Foundation Semiconductor Technology Co., Ltd. (“Chip Foundation”), a manufacturer of semiconductor and integrated circuit devices, for use by Chip Foundation in the co-development of a new generation of microLED-based backlight technology for Liquid Crystal Displays.

Smartkem Chairman and CEO, Ian Jenks, comments, “The first sale of our single layer dielectric materials marks a significant development milestone in our path to establish the commercial viability of our advanced materials in both the display industry and within other applications.”

Smartkem is supplying its proprietary organic dielectric single layer material, or Redistribution Layer (RDL), to Chip Foundation to combine with its own microLED devices, for the joint development of microLED based device structures. The resulting manufactured chip is expected to have the properties of high brightness coupled with high current efficiency, reducing power losses in driving backlights and improving uniformity of illumination.  Additional sales of RDL materials to Chip Foundation are expected to continue throughout 2025.

Dr. Maosheng Hao, Chairman of Chip Foundation, comments, “We are excited to collaborate with Smartkem and integrate their TRUFLEX® materials into our microLED devices. This partnership marks a significant step forward in advancing high-performance backlight solutions for LCDs, combining innovation and efficiency to meet the evolving demands of the display industry.”

Smartkem Receives £900,000 Grant from Innovate UK for Advanced MicroLED Displays

PUBLISHED

DEC 18, 2024 8:25AM EST

Project in partnership with AUO starts on January 1, 2025

MANCHESTER, England, Dec. 18, 2024 /PRNewswire/ — Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics using its disruptive organic thin-film transistors (OTFTs), has received and accepted a £900,000 (USD 1.1 million) grant from Innovate UK for its previously announced project partnership with AUO to develop a rollable, transparent microLED display. Part of the 2024 UK-Taiwan Collaborative R&D Initiative, the 2-year project will commence on January 1, 2025, with initial grant payments beginning in the first quarter of 2025.

About the 2024 UK-Taiwan Collaborative R&D Initiative

The 2024 UK-Taiwan Collaborative R&D Initiative has invested more than £10 million this year to promote bilateral industrial technology research and development cooperation. The nine award-winning projects will promote the joint development of advanced technologies in fields such as electrical information communication, biomedicine, and electromechanical by Taiwan-UK enterprises.

Smartkem Signs Multi-Year Agreement with FlexiIC to Develop a New Generation of CMOS for Smart Sensors

PUBLISHED

DEC 5, 2024 7:45AM EST

New project builds on ongoing collaboration to develop custom circuits using Smartkem’sorganic transistor technology

MANCHESTER, England, Dec. 5, 2024 /PRNewswire/ — Smartkem (NASDAQ: SMTK), which is seeking to change the world of electronics using its disruptive organic thin-film transistors (OTFTs), has signed a multi-year agreement with FlexiIC, a company providing innovation in the design of flexible integrated circuits and systems, to begin a new project to develop a new generation of CMOS for smart sensors.

The goal of the two-year project is the development of custom circuitry using Smartkem’sorganic thin-film transistor (OTFT) technology and n-type oxide TFT to make low-power CMOS enabled sensor devices. The devices are expected to incorporate mixed signal and digital IPs, such as RISC-V cores (a circuit type which uses an open-source instruction set), as well as utilizing machine learning (ML), a type of artificial intelligence (AI) that allows machines to learn and improve from data without being explicitly programmed, to improve processing of signals.

Smartkem Chairman and Chief Executive Officer, Ian Jenks commented, “This project with FlexiIC furthers Smartkem’s technology for potential use in the field of large area, low power consumption electronics suitable for the internet-of-things (IOT), a market which is expected to grow to approximately $4,062.34 billion by 2032, a CAGR or 24.3% from 2024[1]. The use of CMOS architecture in this application is significant as it consumes much less power, has better noise margins, generates less heat and has enhanced scalability compared to alternative PMOS architectures. We are excited to be involved in this ambitious project and, if successful, we believe that this project will demonstrate the utility of Smartkem’s technology in next generation biosensors, force sensors, optical sensors, chemical sensors, item level tracking, and other new areas of flexible electronics.”

FlexiIC co-CEO Dr Eloi Ramon stated “Our innovative sensor acquisition platform offers affordability, adaptability, and eco-friendliness, empowering diverse sensor applications with robust amplification and transmission capabilities to mitigate noise interferences effectively. The partnership in this project with Smartkem to provide custom circuits in foil with low power and a rapid turnaround from design through fabrication is vital to the success of system in foil devices”.

The project commencement is subject to receipt of the approval of grant funding by the Centro para el Desarrollo Tecnológico Industrial (CDTI), a Spanish public entity under the Ministry of Economy and Competitiveness.

About FlexiICFounded by organic electronics researchers and chip designers from the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC), FlexiiC provides innovation in the design of system-on-chip (SoC) solutions for Edge Computing applied to Smart Systems and IoT.

FlexiiC innovates in the development of disposable electronics for Life Sensing by creating and integrating flexible, organic integrated circuits and sensors using sustainable, functional materials. By incorporating advanced computing capabilities, FlexiiC aims to deliver smart, short-lifespan monitoring systems designed for applications in medical & healthcare, packaging, and environmental applications.

NEWS

Smartkem to Participate at SEMICON® China 2025

1 day ago

Smartkem To Unveil First Demo of a MicroLED-in-a-Package (MiP) Backlight at Touch Taiwan 2025

3 days ago

Smartkem Appoints Jonathan Watkins Chief Operating Officer

Mar 10, 2025

Smartkem to Participate at the 37th Annual Roth Conference

Feb 26, 2025

Smartkem to Participate at SEMICON® Korea 2025

Feb 10, 2025

Smartkem Completes First Sale of its TRUFLEX® Semiconductor Materials to Chip Foundation under their Co-Development Agreement

Jan 16, 2025

Smartkem Recaps 2024 Achievements and Sets 2025 Goals

Jan 14, 2025

Smartkem Closes $7.65 Million Offering

Dec 23, 2024

Smartkem Receives £900,000 Grant from Innovate UK for Advanced MicroLED Displays

Dec 18, 2024

Smartkem Prices $7.65 Million Offering

Dec 18, 2024

Smartkem Signs Multi-Year Agreement with FlexiIC to Develop a New Generation of CMOS for Smart Sensors

Dec 5, 2024

Smartkem and AUO Partner to Develop a New Generation of Rollable, Transparent MicroLED Displays

Nov 25, 2024

Smartkem Reports Third Quarter 2024 Financial Results

Nov 12, 2024

Smartkem to Present at the 6th National Conference on Organic Field-Effect Transistors in Hangzhou, China

Nov 6, 2024

Smartkem To Exhibit at TechBlick: The Future of Electronics Reshaped in Berlin, Germany

Oct 21, 2024

Smartkem Announces Joint Development Agreement with Chip Foundation to Co-Develop a New Generation of MicroLED-Based Backlight Technology for Liquid Crystal Displays

Sep 10, 2024

Smartkem to Present and Exhibit at MicroLED Connect 2024

Sep 9, 2024

Smartkem to Present at the PlayNitride 2024 MicroLED Technology Forum and Exhibit at SEMICON® Taiwan 2024

Aug 28, 2024

Smartkem to Present at The International Conference on Flexible and Printed Electronics (ICFPE) 2024

Aug 19, 2024

Smartkem to Present at The 24th International Meeting on Information Display (IMID) 2024

Aug 15, 2024

‍

MANAGEMENT

Ian Jenks

Chairman and Chief Executive Officer

Ian has more than 30 years of board-level experience in the industrial technology industry and has served as chief executive officer of companies operating in the United States and Europe. Ian was formerly the president of Uniphase Inc, Chairman of Oplink Communications Inc which he took public on the NASDAQ and spent seven years as a partner of Crescendo Ventures llp. Ian founded and since August 2010 has acted as the CEO of Ian Jenks Limited, a consulting company providing consulting services to companies in the industrial technology industry. Ian has been a director of Techstep ASA, a provider of managed mobile services in the Nordics, Paysafe plc., an international provider of payment processing services, and Brady plc, a provider of commodity trading software. He also has served and continues to serve as a director of a number of private companies. Ian received a B.Sc. in Aeronautical Engineering from Bristol University.

Beverley Brown

Chief Scientist

Prior to joining Smartkem, Beverley held a number of research and development positions in the technology field of advanced materials at Imperial Chemical Industries Ltd. (“ICI”), Zeneca Group PLC and at the Avecia Group PLC. She formed BAB Consultants Ltd in 2006 and for approximately eight years provided consulting services to a number of chemical companies, as well as to the UK government and to the UK’s Centre for Process Innovation, CPI. Beverley has worked in the field of organic semiconductor technology and in printable electronics for almost 20 years. Beverley holds a Ph.D. in Organic Chemistry from the University of Glasgow.

Barbra Keck

Director and Chief Financial Officer

Barbra Keck was formerly the Chief Financial Officer of Deverra Therapeutics, Inc., a developer of cell therapies. Prior to that, she held positions of increasing responsibility at Delcath Systems, Inc., a Nasdaq-listed interventional oncology company, starting as Controller in 2009 and ultimately becoming chief financial officer in February 2017, a position which she held until 2020.

Simon Ogier

Chief Technology Officer

Simon joined Smartkem as CTO in 2019 and is an internationally recognized expert in the field of organic thin-film transistors. Since 2001 he has worked to develop high performance organic semiconductors for transistor applications within companies such as Avecia, Merck, CPI and more recently with NeuDrive Limited. From 2007 whilst at CPI Simon had a major role in establishing the UK’s National Printable Electronics Centre (PETEC), housing a range of state-of-the-art fabrication equipment for pilot scale production of plastic electronic devices. The facility includes £35m of capital equipment capable of processing substrates up to 370 x 470mm in size. He currently manages a team of 19 engineers and scientists using the equipment for Smartkem’s process development and prototype fabrication. Simon has co-authored 30 journal articles and has been co-inventor on 16 patent families. He serves as the project leader for the standard IEC62899-203 “Semiconductor ink” within IEC TC119 WG2 (Printed Electronics – Materials) and has previously participated in IEEE standards for the organic transistor measurement.‍

‍
Jonathan Watkins

Chief Operating Officer

Jonathan Watkins has over 30 years’ experience commercialising and scaling novel material technologies and working across large multinational companies. He has played pivotal roles in managing complex technical product portfolios and developing global supply chains.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SIX THOUSAND SEVEN HUNDRED FIFTY USD BY LFG EQUITIES CORP FOR A ONE DAY SMTK AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

****Sponsored by Sideways Frequency, LLC

‍

Banzai has added users including Cisco, Nextiva, Sprinklr, Globe Life Insurance, and LoanDepot  Company Welcomed 1,255 Customers in 2024, Demonstrating Robust Adoption and Customer Loyalty!

Banzai Provides Preliminary 2024 Financial Results Including $22.3M Increase to Stockholders’ Equity

Preliminary Unaudited Full Year 2024 Revenue of $17.5 Million Exceed Guidance of $10 Million by 75%, Representing 285% Annual Growth

CHECK OUT THE INVESTOR PRESENTATION HERE

_________________________

Hello Everyone,

Last week was a mess and we are looking to bounce back out of the hole with a familiar name.

This one is known for volatility and double digit swings.

In January it almost DOUBLED in just a few sessions. It closed at 1.25 the day before we profiled it and it was sitting at 2.70 the day after we brought it to your attention.

Right now it is sitting at that CRUCIAL One Buck level that these companies have major incentives to stay on the other side of.

We are watching close for a bounce on Wednesday.

BNZI just recently announced 2 massive acquisitions that are built to add revenues to the companies bottom line. We are talking about $44Million bucks here.

Banzai is a marketing technology company that provides essential marketing and sales solutions for businesses of all sizes. On a mission to help their customers achieve their mission, Banzai enables companies of all sizes to target, engage, and measure both new and existing customers more effectively. Banzai customers include Square, Hewlett Packard Enterprise, Thermo Fisher Scientific, Thinkific, Doodle and ActiveCampaign, among thousands of others.‍

CATALYSTS

The LARGEST platform for finding software and services. More than 100 million people visit Capterra, GetApp, Software Advice, and UpCity across over 70 localized sites every year to read objective research and verified customer reviews that help them confidently choose the right software and services. Thousands of B2B companies work with Gartner Digital Markets to build their brand, capture buyer demand, and grow their business.

Banzai is a SaaS company building an AI-driven platform of essential MarTech data, analytics, and data-driven applications.Banzai is fueling marketing results with cutting-edge AI solutions.

SaaS company building an AI-driven platform of essential MarTech data,analytics, and data-driven applications

• While the global MarTech market is accelerating, marketers are struggling with an explosion of vendor complexity

• Banzai is fueling marketing results with an integrated platform of AI-PoweredMarTech solutions

• Reach deploys multi-channel outbound campaigns and is becoming the marketing automation AI demand gen platform standout• Demio provides transparent webinar insights for data-driven marketers with upstream updates launching in Q4

• Additional upside in strategic acquisitions with a substantial gap between current private vs. at-scale public market valuations.‍

Let’s take a look at some of te reasons we want BNZI on our screen tomorrow:

‍
The company anticipates TRIPLING revenue with the acquisition of OpenReel. Banzai has recently signed a definitive agreement to acquire OpenReel, a digital video creation platform, in a stock deal valued at $19.6 million. OpenReel’s platform enables companies to create high-quality branded video content efficiently, serving enterprise customers including Bristol Myers Squibb, Ingram Micro, and DXC Technology. The acquisition will grow the company’s TTM revenue by 152% to $10.9M!

Strategic business initiatives to improve net income. Banzai announced $13.5M annual net income boost through cost-cutting initiatives and debt restructuring. Strategic cost-saving moves, including a 27% staffing reduction, aim to enhance scalability and extend cash runway.

Impressive Q3 2024 financial results. The company reported that annual recurring revenue for the third quarter soared to $4.4 million, representing a 7% sequential increase from Q2 2024. Net Revenue Retention (NRR) also reached a historic high in Q3 2024 while preliminary, unaudited Q3 2024 Adjusted Net Loss was approximately ($0.9) million, a $3.6 million sequential improvement from Q2 2024 Adjusted Net Loss of ($4.5) million. This represented an annualized improvement of $14.5 million. The cash position reached an all-time high of $4.2 million!

A growing customer base and esteemed partnerships. Banzai saw the addition of 351 new customers in September-October 2024. The company also recently expanded partnerships with Salesforce and HubSpot.

The launch of Curate, a groundbreaking AI-driven newsletter solution. Curate is an AI-powered newsletter platform. Leveraging OpenAI’s GPT-4o, Curate automates the newsletter creation process by writing relevant, branded articles that resonate with target audiences. Curate then publishes content to a branded website and lets users set up daily or weekly updates, keeping their audience engaged with minimal effort and maximum impact.

Demio, the company’s AI-powered webinar platform, has been recognized with multiple accolades. Demio has been recognized by Gartner Digital Markets brands – Capterra, Software Advice, and GetApp.

Gartner Digital Markets is the world’s LARGEST platform for finding software and services. More than 100 million people visit Capterra, GetApp, Software Advice, and UpCity across over 70 localized sites every year to read objective research and verified customer reviews that help them confidently choose the right software and services. Thousands of B2B companies work with Gartner Digital Markets to build their brand, capture buyer demand, and grow their business.

Banzai Announces Definitive Agreement to Acquire Act-On Software, Growing TTM Revenue 152% to $44M

Banzai Adds Enterprise Marketing Automation Platform, the Cornerstone of AI-driven B2B Marketing, to Growing Product Family

SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it has signed a definitive agreement to acquire Act-On Software Inc. (“Act-On”), an enterprise marketing automation platform (MAP) provider.

Act-On is an easy-to-use and intelligent marketing automation platform, powered by AI and supported by an open data architecture. In a landscape filled with complex marketing suites, Act-On focuses on providing marketing software that enhances team efficiency and facilitates engagement with customers and prospects across all communication channels. Clients like Hitachi, BestBuy, and Progressive Insurance utilize Act-On to improve lead generation, increase sales pipeline, automate customer communications, and increase return on marketing investment (ROMI).

“Today’s marketers require efficient and agile marketing automation to achieve tangible business results, and we believe that Act-On provides solutions that fulfill this need,” said Joe Davy, Founder and CEO of Banzai. “Act-On’s software complements our suite of tools for data-driven marketers. By making customer data actionable, Act-On empowers marketers to think big and create smart, effective programs aimed to drive growth and increase customer lifetime value – all with exceptional speed and efficiency.”

“We’re excited to become part of the Banzai product family and contribute to the vision of AI-powered marketing,” said Kate Johnson, CEO of Act-On Software. “The future of marketing software is about making the marketer’s job easier through AI and seamlessly integrated solutions. Banzai’s family of tightly integrated best-in-class products – including webinar tools, video creation, and now marketing automation – will help marketers accomplish more in an AI empowered world.”

The acquisition is projected to increase revenue by $27 million for the twelve-month period ending December 31, 2025, on a pro forma basis. Act-On’s financials are forecasted and are subject to change.

Banzai’s vision is to build a comprehensive suite of AI-driven marketing tools that make life easier for marketers and businesses of all sizes. Acquiring Act-On is a key step toward achieving this goal, driving revenue growth, and providing innovative solutions for our clients.

Transaction Details

Under the terms of the agreement, the aggregate merger consideration will consist of Banzai Class A Common Stock, and/or Pre-Funded Warrants exercisable for shares of Class A Common Stock, valued at $33.2 million and cash consideration of $20.0 million for an aggregate enterprise value for the merger consideration of $53.2 million. Additional details regarding the acquisition are included in the Company’s Form 8-K filed with the Securities and Exchange Commission on January 23, 2025. The transaction is expected to close in February 2025, subject to the satisfaction of customary closing conditions.

About Act-On Software

Act-On Software is the easiest to use and most intelligent marketing automation platform for mid-market and enterprise B2B customers. Act-On provides solutions that empower marketers to engage prospects and customers at every step of the customer lifecycle, including lead generation, automated multi-channel marketing, customer journey orchestration, email personalization, customer data management, and sales intelligence. By unifying customer engagement data and multi-channel outreach, Act-On makes it easy for brands to reach and engage their target buyers with personalized messages. Act-On Software serves enterprise customers such as Hitachi, Sharp, Best Buy, Flextronics, Red Lions Hotels, and SKF Group. Act-On is headquartered in Portland, Oregon. Learn more at https://act-on.com.

Banzai Signs Acquisition of Vidello, Growing TTM Revenue 59% to $17.3M and Adding $2.3M in EBITDA

Banzai to Expand Portfolio with Vidello: Next-Generation Video Creation, Editing, and Marketing Suite

Expected to add $6.5M in Revenue and $2.3M in EBITDA for the TTM Through September 30, 2024

SEATTLE, Dec. 20, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it has signed a definitive agreement to acquire Vidello, a technology provider of video hosting and marketing suite solutions for businesses.

The acquisition is expected to grow revenue by $6.5M and increase EBITDA by $2.3M for the twelve-month period ended September 30, 2024 on a pro-forma basis. Vidello financials are preliminary and unaudited, and subject to adjustment. Banzai will pay up to an aggregate of $7M in a mix of cash equity to Vidello’s shareholders, subject to certain holdback amounts and future performance targets.

Based in London, Vidello offers a comprehensive video hosting and marketing suite that provides entrepreneurs, startups, agencies, and online businesses with tools to grow their businesses.

Vidello’s key offerings include:

• CreateStudio: An award-winning video creation app that allows users to easily produce eye-catching 3D character video content for social media and websites.
• PhotoVibrance: A tool that transforms static images into moving motion pictures to capture attention.
• Twinkle: An all-in-one audio platform for creators and agencies, featuring premium royalty-free music tailored for video projects.
• Vidello: A 3-in-1 video hosting, player, and collaboration tool that allows users to showcase videos with a customizable, lightning-fast player. Features include a collaboration portal and in-play marketing calls-to-action for lead generation and sales optimization.

Vidello has over 90,000 customers. Their flagship CreateStudio product has been named a Top 3 Best Rated product in the video maker category by Capterra1, and a High Performer by G22.

“We’re doubling down on building the best suite of video products by adding Vidello. We believe that Vidello has created the best product in the world for making amazing 3D videos,” said Joe Davy, Founder and CEO of Banzai. Mr. Davy expressed his further excitement about the acquisition by stating his belief that “Video content is the future of marketing across every platform. Vidello’s products make it significantly easier to create stunning, attention-grabbing video content without any technical expertise.”

Josh Ratta, Co-Founder and CEO of Vidello, commented, “Having established a strong presence in the video space, we’re thrilled to partner with Banzai. This collaboration comes at the perfect time, offering an exciting opportunity to expand our video tools and reach a wider audience. By integrating Vidello’s capabilities with Banzai’s AI-powered platform, we strive to help businesses create and host engaging videos that elevate their marketing efforts.”

Banzai’s vision is to build a comprehensive suite of AI-powered marketing tools that make marketers lives faster and easier. The Vidello acquisition will play a pivotal role in accelerating revenue growth by delivering innovative solutions to our customers.

Transaction Details

Under the terms of the agreement, the aggregate merger consideration shall be up to $5.5Min cash (subject to certain holdback amount as set forth in the acquisition agreement) and a number of shares of Banzai Class A Common Stock, and/or Pre-Funded Warrants in lieu thereof, equal to $1.5 million. Additional details regarding the acquisition are included in the Company’s Form 8-K filed with the Securities and Exchange Commission on December 20, 2024. The transaction is expected to close in December 2024, subject to the satisfaction of customary closing conditions.

About Vidello

Vidello is a video hosting and marketing suite which provides online businesses with the essential marketing and hosting tools to assist in growing business through video. To learn more about the company visit www.vidello.com.

‍

Banzai Provides Preliminary 2024 Financial Results Including $22.3M Increase to Stockholders’ Equity

PUBLISHED

MAR 12, 2025 8:31AM EDT

Preliminary Unaudited Full Year 2024 Revenue of $17.5 Million Exceed Guidance of $10 Million by 75%, Representing 285% Annual Growth

Stockholders’ Equity Increase of Approximately $22.3 Million Since September 30, 2024

Continues Progress Toward Closing of Acquisition of Act-On Software, Inc.

SEATTLE, March 12, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today provided preliminary unaudited record pro-forma revenue of $17.5 million for the year ended December 31, 2024 and provided a corporate update on its stockholder equity improvement.

Full Year 2024 Revenue Results

Banzai preliminary unaudited revenue is expected to be $17.5 million for the year ended December 31, 2024, on a pro-forma basis including full year revenue for the recently closed acquisitions of Vidello and OpenReel. This is an increase of 285% from the prior year, and exceeds the top end of the Company’s previously announced guidance of $10 million for the full year of 2024 by 75%.

Preliminary selected financial information presented in this release are unaudited, subject to financial closing procedures and adjustments, and provided as an approximation on a pro-forma basis in advance of the Company’s announcement of its complete financial results for the full year 2024.

Stockholders’ Equity Increase

Banzai’s equity value as of February 28, 2025, reflects an overall total stockholders’ equity increase of $22.3M. The equity value of the total stockholders’ deficit was ($22.8) million on September 30, 2024, as per the Company’s 10-Q for the period. This increased to approximately ($0.5) million as of February 28, 2025, an improvement of approximately $22.3 million.

Continued Progress on Act-On Acquisition

The Company continues to make progress toward closing the acquisition of Act-On Software, Inc. The definitive agreement for the acquisition was previously announced on January 23, 2025.

Management Commentary

“Full year 2024 revenue was driven by strong organic growth and from our Vidello and OpenReel acquisitions,” said Joe Davy, Founder and CEO of Banzai. “Vidello’s next-generation video creation, editing, and marketing suite, and OpenReel’s digital video creation platform combined to add approximately $13 million in revenues that enabled us to greatly exceed our previously announced 2024 guidance.

“With the investment in our Vidello acquisition, we further improved our financial position and flexibility with a $22.3 million improvement in stockholders’ equity from the close of the third quarter of 2024. The acquisition is also expected to increase EBITDA by approximately $2 million for the twelve-month period ended December 31, 2024, on a pro-forma basis. I look forward to sharing our full year 2024 results soon as we look ahead to the second half of the year,” concluded Davy.

About Vidello

Vidello is a video hosting and marketing suite which provides online businesses with the essential marketing and hosting tools to assist in growing business through video. To learn more about the Company visit www.vidello.com.

About OpenReel

OpenReel is a leading enterprise video creation and management solution that empowers companies to create high-quality content at scale and on brand. OpenReel enables businesses of all sizes to cut down on the time-and resource-intensive process of video creation and scale content creation initiatives efficiently, effectively, and securely. OpenReel is trusted by a wide range of customers from small businesses to the Fortune 500. OpenReel is based in New York, with its team distributed worldwide. To learn more about the company, visit www.openreel.com.

Banzai Announces Definitive Agreement to Acquire OpenReel, Growing TTM Revenue 152% to $10.9M

Banzai Adds Enterprise-Grade Branded Video Creation and Management Solution OpenReel to Growing Product Family

BNZI has signed a definitive agreement to acquire OpenReel, a leading digital video creation platform.

OpenReel enables companies to rapidly create high-quality, branded video content. Their solution allows companies to direct, record, create, and collaborate on high-definition video projects, dramatically reducing the time to create brand-compliant video content. OpenReel’s enterprise customer base includes global organizations, such as Bristol Myers Squibb, Ingram Micro, DXC Technology, Insider Inc., and US Steel.

“Video is the future of enterprise marketing,” said Joe Davy, Founder and CEO of Banzai. “OpenReel gives their customers a 10x advantage when creating branded video content. Their enterprise customers are a testament to the power of their solution.”

“We’re thrilled to join the Banzai family and take OpenReel to new heights,” said Lee Firestone, CEO and co-founder of OpenReel. “With Banzai’s support, we’re confident in accelerating the growth of our technology while becoming an integral part of their robust suite of marketing tools. We believe that OpenReel is the perfect complement to Demio, enabling seamless cross-collaboration and enhancing the value we deliver to marketers worldwide.”

OpenReel is a leading enterprise video creation and management solution that empowers companies to create high-quality content at scale and on brand. OpenReel enables businesses of all sizes to cut down on the time-and resource-intensive process of video creation and scale content creation initiatives efficiently, effectively, and securely. OpenReel is trusted by a wide range of customers from small businesses to the Fortune 500. OpenReel is based in New York, with its team distributed worldwide.

BNZI’s vision is to build an AI-powered marketing technology platform to help businesses of all sizes grow.

Banzai Announces Expanded Partnership with Salesforce, Today’s Industry Leading AI CRM Company for Smarter Webinar Campaigns

Simplified Workflows and Real-Time Insights with Account Engagement Integration in Demio Give Salesforce Users the Tools They Need to Enhance Their Webinar Strategy

SEATTLE, Oct. 17, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced significant enhancements to its Demio platform through deeper integration with Salesforce, the industry leading AI CRM company.

These new features address key operational challenges faced by marketing teams, delivering an improved level of precision in webinar data management, from automated lead capture to real-time UTM tracking. Marketers leveraging this integration will not only see immediate efficiency gains but will also benefit from enhanced decision-making capabilities, thanks to cleaner, more accurate data pipelines.

Key Enhancements Designed to Maximize Efficiency and Insight

This integration addresses common pain points for Salesforce Account Engagement users by automating the syncing of webinar data—from contact information to UTM tracking—greatly reducing the time and effort required for manual processes. Marketers can now focus on optimizing campaigns with real-time insights, enabling data-driven adjustments with speed and precision. The seamless UTM tracking integration offers a comprehensive view of campaign performance across channels, while Demio’s smart list management feature ensures that webinar registrants are automatically added to targeted Salesforce Account Engagement lists, ensuring no lead slips through the cracks.

Key capabilities include:

• Automated List Management: Simplify the process by automatically syncing registrants to Salesforce Account Engagement, ensuring optimal engagement across the funnel.
• Real-Time UTM Tracking: Gain holistic insights into campaign performance with real-time tracking at both session and individual contact levels.
• Advanced Search for List Management: Quickly navigate extensive lists with Demio’s new auto-search feature, saving time and boosting productivity.
• Custom Field Syncing: Ensure accurate and up-to-date information across platforms, enabling targeted segmentation and precision marketing.

Joe Davy, CEO of Banzai, emphasized the power of this upgraded integration: “By deepening our connectivity with Pardot, we’re offering marketers a more scalable, data-rich experience. This isn’t just a product enhancement; it’s a strategy shift that will drive better outcomes with less effort.”

A Future-Focused Solution for Salesforce Customers

Banzai continues to innovate to ensure its solutions meet the evolving needs of marketing teams. By integrating powerful features directly into users’ workflows, this enhancement sets a new standard for what’s possible in webinar campaign management—paving the way for more strategic, data-driven marketing operations.

About Salesforce

Salesforce is the #1 AI CRM, empowering companies to connect with their customers in a whole new way through the power of CRM + AI + Data + Trust on one unified platform: Einstein 1. For more information visit: www.salesforce.com.

NEWS

New to The Street’s FOX Business Show #638 Spotlights Visionary CEOs and Breakthrough Innovations Across Health, AI, and Insurance Featuring BioVie CEO Cuong Do, Roadzen CEO Rohan Malhotra, Lou Basenese’s The Big Skinny on eXoZymes, and Banzai CEO Jo…

1 day ago

Banzai Provides Preliminary 2024 Financial Results Including $22.3M Increase to Stockholders’ Equity

Mar 12, 2025

FE International Advises on the Acquisition of Vidello by Banzai International, Inc.

Mar 4, 2025

Banzai Launches CreateStudio 4.0, with Major A.I. Enhancements for Video Creation

Feb 25, 2025

Banzai Fully Regains Compliance with Nasdaq Continued Listing Requirements

Feb 13, 2025

Banzai Completes Acquisition of Vidello, Growing TTM Revenue 59% and Adding $2M in EBITDA

Feb 3, 2025

Banzai Announces Definitive Agreement to Acquire Act-On Software, Growing TTM Revenue 152% to $44M

Jan 23, 2025

Banzai Signs Acquisition of Vidello, Growing TTM Revenue 59% to $17.3M and Adding $2.3M in EBITDA

Dec 20, 2024

Banzai Completes Acquisition of OpenReel, Expects to Exceed $10.0 Million 2024 Revenue Guidance

Dec 19, 2024

Banzai Appoints Nancy Norton as Chief Legal Officer

Dec 18, 2024

Banzai Announces Definitive Agreement to Acquire OpenReel, Growing TTM Revenue 152% to $10.9M

Dec 10, 2024

Banzai to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

Dec 6, 2024

iAccess Alpha’s Buyside Best Ideas Virtual Winter Conference December 10-11, 2024

Dec 6, 2024

New to the Street Engages Curate by Banzai to Elevate Investor and Brand Engagement

Dec 4, 2024

Banzai Engages ShareIntel to Investigate Potentially Improper and Illegal Trading Activity in the Company’s Common Stock

Dec 4, 2024

Banzai Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Nov 26, 2024

Banzai’s Demio Wins Multiple Recognitions from Gartner Digital Markets in 2024

Nov 19, 2024

Banzai Reports Third Quarter 2024 Financial Results; Annualized Adjusted Net Loss Improvement of $12.2 Million

Nov 14, 2024

Banzai Regains Compliance with Nasdaq Minimum Market Value of Publicly Held Shares Requirement

Nov 11, 2024

Banzai Q3 2024 Preliminary Financial Results: Profitability in Sight Following $14.5M Annualized Adjusted Net Income Improvement; 31% Annualized ARR Growth Rate

Nov 7, 2024

Banzai Announces Listing Transfer to Nasdaq Capital Market Pursuant to Nasdaq Compliance Plan

Nov 4, 2024

Banzai Launches Curate: A Groundbreaking AI-Driven Newsletter Solution

Oct 31, 2024

Banzai to Host Third Quarter 2024 Results Conference Call on Thursday, November 14, 2024 at 5:30 p.m. Eastern Time

Oct 30, 2024

Banzai Regains Compliance with NASDAQ Minimum Bid Price Rule

Oct 22, 2024

‍

‍

MANAGEMENT

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SIX THOUSAND USD BY SIDEWAYS FREQUENCY LLC FOR A ONE DAY BNZI AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

****Sponsored by LFG Equities Corp.

LQR House Reports 118.67% Month-Over-Month Revenue Growth in February 2025 Compared to January 2025, Achieves 63.82% Year-Over-Year Revenue Increase in February 2025 Compared to February 2024 With $0 Spent on Paid Advertising

In January 2025, LQR House recorded revenues of $151,635.94

LQR House Inc. Announces Share Acquisition by MeiFang Group at $1.58/Share and Agreement for Share Acquisition by Winz Technology Co. at $2.85/Share, Along With Highly Qualified Board Nominations

READ THE INVESTOR PRESENTATION HERE

_________________________

Hello Everyone,

We are looking to finish the week strong with a brand new profile.

We saw two high flyers and quick runners this week.

Both of our profiles made extremely strong moves off of the open before pulling back.

This next one is priced a little bit higher but still sitting right in the wheel house we love to bring to our members.

Pull up YHC and get ready to watch this one in the morning.

This one has been on the move and has closed green 12 of the last 16 including a nice healthy pullback that we saw take place today!

Check out what YHC has been up to this month. Yes this is a 1 month chart you are looking at here.

This one was just sitting at a buck and has been chewing through any resistance and looks like it wants to tackle the $3 level.

Why the move? Well, the company has put out some strong revenue news and some other factors could be coming into play.

Regardless, this one looks incredible right here and has been bucking the trend and going against the market.

Before we get into the revs let’s take a look at the company:

LQR House intends to become a prominent force in the wine and spirits e-commerce sector, epitomized by its flagship alcohol marketplace, cwspirits.com. This platform seamlessly delivers a diverse range of emerging, premium, and luxury spirits, wines, and champagnes from esteemed retail partners like Country Wine & Spirits. Functioning as a technology-driven hub, LQR House utilizes software, data analytics, and artificial intelligence to elevate the consumer experience. CWSpirits.com stands out as the go-to destination for modern, convenience-oriented shoppers, providing a curated selection of alcohol products delivered to homes across the United States. Beyond its role in an e-commerce sector, LQR House is a marketing agency with a specialized focus on the alcohol industry. The Company measures campaign success by directly correlating it with sales on CWSpirits.com, demonstrating a return on investment. Backed by an influential network of over 550 figures in the alcohol space, LQR House strategically drives traffic to CWSpirits.com, enhancing brand visibility. LQR House intends to disrupt the traditional landscape of the alcohol industry, driven by its dedication to providing an unparalleled online purchasing experience and delivering tailored marketing solutions.

LQR House Reports 118.67% Month-Over-Month Revenue Growth in February 2025 Compared to January 2025, Achieves 63.82% Year-Over-Year Revenue Increase in February 2025 Compared to February 2024 With $0 Spent on Paid Advertising

PUBLISHED

MAR 5, 2025 8:00AM EST

Company’s Strategic Shift to SEO-Driven Growth Continues to Deliver Outstanding Results

MIAMI BEACH, FL / ACCESS Newswire / March 5, 2025 / LQR House Inc. (the “Company” or “LQR House”) (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, proudly announces a remarkable 118.67% revenue growth in February 2025 compared to January 2025, demonstrating the resilience and strength of its organic growth strategy. Additionally, year-over-year revenue surged 63.82% compared to February 2024, reaffirming the Company’s successful transition from paid advertising to a strategic, SEO-driven approach, moving forward to potential profitability under the guidance and direction of LQR House’s newest board members. This milestone further validates the Company’s data-driven marketing strategy, which prioritizes long-term, sustainable growth over short-term ad spend.

LQR House recorded $331,582.11 in revenue for February 2025, marking a significant increase from $202,404.64 in February 2024. This growth is particularly noteworthy considering that in February 2024, the Company spent $19,344.47 on paid advertising to drive traffic and sales, whereas in February 2025, revenue surged with zero ad spend. The Company believes that such growth is a testament to the effectiveness of strategic organic marketing initiatives. Moving forward, the Company expects this momentum to continue as it further refines its SEO-driven strategy while expanding the wholesale distribution of its own tequila brand.

Furthermore, the Company’s month-over-month revenue increased by an 118.67%, rising from $151,635.94 in January 2025 to $331,582.11 in February 2025-an especially impressive feat considering February is a shorter month.

“Last month, we saw incredible results after cutting back on paid advertising, so we continued down this path in February,” said Sean Dollinger, CEO of LQR House. “What’s most exciting is that, despite removing paid ads entirely, our numbers exceeded even my most optimistic expectations. Not only did revenue surge by over 118% month-over-month, but we also posted a 63.82% increase in February compared to the same month last year-all while spending significantly less on advertising. We believe that this validates our strategic shift towards SEO and organic traffic, proving that sustainable growth doesn’t require excessive marketing spend but rather smart, targeted execution. We believe that we are now on a stronger path, allocating resources more effectively and setting the stage for future profitability.”

LQR House Inc. Announces Share Acquisition by MeiFang Group at $1.58/Share and Agreement for Share Acquisition by Winz Technology Co. at $2.85/Share, Along With Highly Qualified Board Nominations

PUBLISHED

NOV 27, 2024 8:30AM EST

MIAMI BEACH, FL / ACCESSWIRE / November 27, 2024 / LQR House Inc. (the “Company” or “LQR House”) (NASDAQ:LQR), a niche e-commerce platform specializing in the spirits and beverage industry, announced today a transformative step forward under the guidance of activist investor David Lazar. Mr. Lazar has entered into a Securities Purchase Agreement (the “SPA”) with both MeiFang Group & Winz Technology Co., signaling a strategic alignment aimed at advancing LQR House’s market position and fostering sustainable growth.

As part of the agreement, MeiFang Group acquired 821,818 shares of common stock from Mr. Lazar for $1,300,000, representing a valuation of $1.58 per share. Similarly, Winz Technology Co. is set to acquire 280,000 shares of common stock from Mr. Lazar for $800,000, reflecting a valuation of $2.85 per share.

Thanks to David Lazar’s extensive network, LQR House is pleased to announce the nomination of two highly qualified candidates, Yilin Lu and Hong Chun Yeung, to its Board of Directors. These appointments are pending shareholder approval and, with their exceptional expertise in capital markets and business strategy, are expected to elevate the Company’s leadership and drive its future growth.

Yilin Lu, a Chartered Financial Analyst (CFA) and Financial Risk Manager (FRM), brings over 15 years of experience in equity investment and trading. Since June 2023, Mr. Lu has served as the Founder and CEO of Senchi Morgan Capital Market and Senchi Morgan Asset Management, renowned broker-dealer and asset management firms. Mr. Lu began his investment banking career at Goldman Sachs in 2006 and subsequently held leadership roles at China International Capital Corporation (CICC) and Cantor Fitzgerald Capital Market in Hong Kong. He established his first investment bank in 2016 and later served as the Founder and CEO of Cheung On Securities Limited. His extensive background in global financial institutions positions him as a key asset in guiding LQR House’s growth and market strategy.

Hong Chun Yeung, a practicing member of the Hong Kong Institute of Certified Public Accountants, has around 13 years of experience in auditing, M&A advisory, and pre-listing consultation. As a Director of Zhonghui Anda CPA since 2014, Mr. Yeung has provided strategic oversight to companies in manufacturing, mining, logistics, and engineering. His expertise in audit and assurance services complements LQR House’s focus on operational transparency and financial growth.

Sean Dollinger, CEO of LQR House, expressed his enthusiasm for the new appointments:”I’ve had the privilege of meeting Yilin Lu, and I could not be more impressed with everything he has accomplished. His extensive background at some of the world’s most respected investment banks is an invaluable asset to LQR House. We are incredibly excited to see how his vision and expertise will shape the future of our Company. With both Mr. Lu and Mr. Yeung on our board, we are confident that LQR House is poised to reach new heights.”

With the strategic partnership with MeiFang Group & Winz Technology Co. and the addition of highly experienced board members, LQR House is set to strengthen its capital markets strategy, broaden its investor network, and unlock new opportunities in the spirits and beverage industry.

Additionally, LQR House has filed a definitive proxy statement on Schedule 14A with the Securities and Exchange Commission, which is publicly available at www.sec.gov. The proxy statement includes information about the director nominees. We anticipate commencement of the dissemination of the proxy statement will begin on November 27, 2024.

‍

BRANDS

NEWS

‍
LQR House Secures Coinbase Prime for Bitcoin Custody and Treasury Management

3 days ago

LQR House Reports 118.67% Month-Over-Month Revenue Growth in February 2025 Compared to January 2025, Achieves 63.82% Year-Over-Year Revenue Increase in February 2025 Compared to February 2024 With $0 Spent on Paid Advertising

Mar 5, 2025

LQR House Inc. Maintains Steady Year-Over-Year Revenue Despite Eliminating Paid Advertising, Showcasing SEO Strength While Advancing Profitability Strategy

Feb 24, 2025

LQR House Inc. Announces Mr. Lijun Chen as Chairman and Dr. Jing Lu as New Board Member

Dec 20, 2024

LQR House Inc. Announces Change of Ticker Symbol From “LQR” to “YHC” Effective December 16, 2024

Dec 13, 2024

LQR House Inc. Secures Liquor Control Board of Ontario (LCBO) Approval for SWOL Tequila in Ontario

Dec 3, 2024

LQR House Inc. Announces Share Acquisition by MeiFang Group at $1.58/Share and Agreement for Share Acquisition by Winz Technology Co. at $2.85/Share, Along With Highly Qualified Board Nominations

Nov 27, 2024

LQR House Inc. Elevates SWOL Tequila With Sleek New Bottle Design and Exclusive Golden Ticket Campaign

Nov 26, 2024

LQR House Inc. Board of Directors Approves Purchase of Up to $1M Bitcoin as Treasury Reserve Asset and Retention of Up to $10M Crypto Payments on CWSpirits.com

Nov 19, 2024

LQR House Announces Marketing Partnership with the New York Cocktail Co. to Drive Awareness and Sales of Their Negroni Cocktail on CWSpirits.com

Nov 6, 2024

LQR House Inc. Reports 424.58% Year-Over-Year Revenue Growth in October 2024 Compared to October 2023

Nov 4, 2024

LQR House Announces Marketing Partnership With Region De Mexico Tequila Brand

Oct 30, 2024

LQR House Announces First Shipment of SWOL Tequila for LCBO Review

Oct 23, 2024

LQR House Inc. Implements Strategic Cost-Cutting Measures Under Activist Investor David Lazar’s Leadership

Oct 21, 2024

LQR House Inc. Announces Agreement With Activist Investor David Lazar for $3 Million Investment in Exchange for 5,454,545 Shares at $0.55 and His Appointment as Board Member and President

Oct 16, 2024

LQR House Announces Marketing Partnership With Big Spoon to Drive Awareness for Non-Alcoholic Ready-to-Drink Product Line

Oct 9, 2024

LQR House Inc. Announces 5700% Year-Over-Year Revenue Growth for September 2024

Oct 2, 2024

LQR House Announces Strategic Marketing Partnership With Florena to Enhance Brand Awareness and Drive Sales

Sep 16, 2024

LQR House Announces Marketing Partnership With Higher Celebrations for ‘The HotShot’

Sep 5, 2024

LQR House Inc. Announces 540% Year-Over-Year Revenue Growth for August 2024

Sep 4, 2024

‍

MANAGEMENT

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SIX THOUSAND FIVE HUNDRED USD BY LFG EQUITIES CORP FOR A ONE DAY YHC AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

****Sponsored by LFG Equities Corp.

DEVS is the first and only pure-play carbon-credit company to list on a major U.S. exchange

DEVS has more than 140 projects in its pipeline, with more than a dozen signed contracts representing an opportunity to generate 30 million+ credits per year

Polar Asset Management Partners Inc. Acquires Stake in DevvStream Corp

DevvStream Adds Hydroelectric Power Facility to its Asia I-REC Program

READ THE INVESTOR PRESENTATION HERE

_________________________

Hello Everyone,

Our last profile turned out to be a high flyer and fast mover until it “appears” like some algorithms took over and sent this one to 1.79 after opening at .93. It was trading down in the .80’s in the premarket. This was a 100%+ move during the session off of the previous sessions close. I hope that you watched this monumental move before it came back down to earth.

We have another company for you to look at for Thursday’s session.

This is another company that we have never profiled before and we are extremely excited to bring to our members.

Pull up DEVS right away.

You will notice that this one is having big day today on Wednesday on the back of some significant news.

You want to make sure you research this one thoroughly and read everything we have to say before you start your own due diligence.

To understand DEVS you need to understand what carbon credits are. They are a financial tool designed to help organizations advance decarbonization efforts by funding environmentally conscious projects. The carbon market is already a $1T market according to many reports which also expect it to double over the next 4 years or so.

DEVS is a leading authority in the use of technology in carbon project development.

The company’s mission is to create alignment between sustainability and profitability, helping organizations achieve their climate initiatives while directly improving their financial health.

The company is involved in a number of green initiatives with the ultimate goal of reducing the impact of climate change.

DEVS works with governments and corporations worldwide to achieve their sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissioBns, and sequester carbon directly from the air. DEVS also helps these organizations meet their net zero goals by providing them access to high-quality carbon credits.

What they do is  partner with companies that have technologies that are eligible for generating carbon credits, producing the credits on their behalf.  

DevvStream then gets 25% of the credits that are generated for the life of the project. This has the potential to be highly lucrative since the company isn’t investing in the project itself.  

The company has more than 140 of these projects in its pipeline, with more than a dozen signed contracts representing an opportunity to generate 30 million+ credits per year.

Over the past year, the company has announced several signed contracts with EV charging networks to help them generate carbon credits. These include:

• Texas-based Go-Station
• New York City-based Green Energy Technology
• India-based E-Fill Electric
• Florida-based OK2Charge

The de-SPAC merger generated two major business developments for DEVS.

The first was to enter into agreements to stockpile carbon credits, including 1.2 million credits for conservation of 200,000 hectares of Amazon territory and 2.5 million credits “selected from a field of over 120 million potential carbon credits from dozens of other projects.”

The second major development was there of a 50% equity stake in Monroe Sequestration Partners (MSP) and its carbon sequestration operations.

MONROE PROJECT

Project Revenues are expected to be generated from:

•⁠  ⁠Storage fees from accepted CO2 to be sequestered

•⁠  ⁠Up to 260M 45Q Tax Credits

•⁠  ⁠Sale of up to 260M carbon credits

45Q tax credits are generated via a US tax credit program that incentivizes carbon capture, utilization, and storage (CCUS) projects
•⁠  ⁠45Q tax credits are transferable and are valued at up to $85 per ton of CO2 stored.

I-REC

Late last year, DEVS announced that it will be diversifying its revenue streams to include renewable energy certificates (I-RECs).

An I-REC is generated when a power plant generates 1MWh of renewable energy. It can then be sold to companies that need them to maintain their commitments to renewable energy.

These days, some of the largest companies in the world — heavyweights such as  Apple, Google, Microsoft, and Samsung — have commitments to use 100% renewable energy, which often requires buying I-RECs.
DevvStream has secured exclusive agreements in Asia’s renewable energy market:
Medellin Solar Power Facility (Philippines): A 730 MWp project capable of generating over 1.2 million I-RECs per year.
PT.Siteba Hydroelectric Facility (Indonesia): An already operational hydro facility expected to generate I-RECs in 2025

‍

Polar Asset Management Partners Inc. Acquires Significant Stake in DevvStream Corp

Transaction Overview

Polar Asset Management Partners Inc. recently executed a notable transaction by acquiring 558,415 shares of DevvStream Corp on December 31, 2024. The shares were purchased at a price of $0.752 each, marking a strategic move by the firm. This acquisition represents a new holding in Polar Asset Management’s portfolio, with DevvStream Corp now accounting for 0.01% of the firm’s total investments. The transaction reflects Polar Asset Management’s interest in expanding its portfolio within the technology and environmental sectors.

Polar Asset Management Partners Inc is a well-regarded firm known for its expertise in value investing. The firm manages an equity portfolio valued at $3.44 billion, with significant investments in the Financial Services and Technology sectors. Some of its key holdings include Sprott Physical Gold Trust, Sprott Physical Silver Trust  and Insulet Corp. The firm’s strategic investment decisions are guided by a focus on long-term value creation and market opportunities.

DevvStream Announces Additional Investment

PUBLISHED

MAR 19, 2025 9:00AM EDT

Investment by Chairman Carl Stanton and Director Wray Thorn reinforces confidence in DevvStream’s mission

Calgary, Alberta–(Newsfile Corp. – March 19, 2025) – DevvStream Corp. (NASDAQ: DEVS) (“DevvStream” or the “Company“), a leading carbon management firm specializing in the development, investment, and sale of environmental assets, energy transition, and innovative carbon management solutions, today announced that Carl Stanton, Chairman of DevvStream, and Wray Thorn, Director, have invested an additional $218,000 into the Company’s 5.30% Secured Convertible Note, due November 2026.

The funds support DevvStream’s ongoing efforts to expand into energy transition markets, grow its partnerships and solidify its position as a leader in the carbon offset market. Stanton and Thorn are also co-founders of Focus Impact Partners.

DevvStream Boosts Carbon Offset Initiative Through E-Commerce Partnerships

PUBLISHED

MAR 18, 2025 9:00AM EDT

Partnering with e-commerce agencies, technology integrators, and 3PL providers to drive adoption of its D-PIVOT carbon offset tool across Shopify storefronts

New agreements with Zing (e-commerce marketing/software) and Minimus Fulfillment (3PL for celebrity and creator brands) strengthen DevvStream’s leadership in the carbon offset market

Calgary, Alberta–(Newsfile Corp. – March 18, 2025) – DevvStream Corp. (NASDAQ: DEVS) (“DevvStream” or the “Company“), a leading carbon credit project co-development and generation firm specializing in technology-based solutions, today announced a major expansion of its e-commerce sustainability strategy through partnerships designed to accelerate adoption and revenue growth for its previously announced DevvStream Personal Impact Voluntary Offset Tool (“D-PIVOT“).

D-PIVOT is a free Shopify-integrated software tool that enables consumers to offset the carbon footprint of their online purchases by supporting verified, high-integrity environmental projects, including clean water access, rainforest preservation, and indigenous-led conservation programs. It is made available primarily through wholesalers, fulfillment providers, and distributors, allowing businesses to offer a seamless sustainability solution for environmentally conscious customers. D-PIVOT can be found at https://apps.shopify.com/carbon-emissions.

By forming strategic partnerships with e-commerce marketing agencies, technology integrators, and third-party logistics (“3PL“) providers, DevvStream is positioned to drive rapid scale across the Shopify ecosystem, which powers approximately 28% of all online stores in the United States. This also provides the Company with a strong sales channel for its inventory of several million high-quality carbon credits.

Strategic Market Opportunity: Tapping into High-Growth E-Commerce Sectors

E-commerce continues to be a dominant force in U.S. retail, with logistics, marketing, and technology integration services growing at an accelerated rate. This represents a major revenue opportunity for DevvStream:

• Third-Party Logistics Providers: The U.S. 3PL market generated approximately $299.5 billion in gross revenue in 2023, with projections exceeding $350 billionby 2030. Parcel shipments are growing by 5% annually, creating an ongoing need for sustainable shipping solutions.
• E-Commerce Marketing & Media Agencies: The U.S. digital advertising agency market is expected to generate $52.4 billion in revenue in 2024, up 10.3% year-over-year, reflecting continued investment in e-commerce brands.

With D-PIVOT, DevvStream is positioned to capitalize on these trends by embedding sustainability into online transactions at scale.

Partnerships with Zing and Minimus Fulfillment: Scaling DevvStream’s Reach Across Shopify

To accelerate market penetration, DevvStream has signed agreements with two leading companies. These partnerships are expected to facilitate the introduction of D-PIVOT to online retailers looking to enhance their sustainability efforts.

• Zing, an e-commerce marketing and software development company, provides access to a diverse portfolio of online brands seeking sustainability integrations.
• Minimus Fulfillment, a leading 3PL provider serving high-profile clients, provides DevvStream with access to retailers actively looking for sustainability-friendly shipping solutions.

“Partnering with Zing and Minimus Fulfillment represents a major step forward in our mission to make carbon offsetting accessible at the point of purchase,” said Sunny Trinh, CEO of DevvStream. “With e-commerce reshaping consumer habits, this initiative enables us to scale revenue while embedding sustainability into everyday transactions. By collaborating with key players in the online retail ecosystem, we can scale D-PIVOT’s impact and empower businesses to offer meaningful climate action to their customers.”

“At Zing, we work with a diverse portfolio of e-commerce brands that are constantly looking for innovative ways to enhance customer experience and align with consumer values,” said Dan Melnick, CEO and Co-Founder of Zing. “Integrating DevvStream’s D-PIVOT solution allows our clients to offer seamless carbon offset options at checkout, adding both sustainability and customer engagement benefits. DevvStream’s expertise in high-integrity carbon credits makes them the ideal partner for this initiative, ensuring that the offsets are both impactful and transparent.”

“Minimus Fulfillment is excited to be working with the D-PIVOT Shopify plugin to offer it to our fulfillment clients,” said Paul Shrater, CEO of Minimus Fulfillment. “We enjoy sharing unique opportunities that can enhance our client’s businesses as we view them as client-partners and not just as a client/vendor relationship. Consumers, more so than ever, are looking for ways to feel an emotional connection to the brands they purchase from, and by providing a way for them to offset the carbon footprint of their purchases, brands can bring this experience to their customers in a trusted way, utilizing highly vetted carbon credits from a plugin developed by the only carbon credit company that is public on the Nasdaq exchange.”

NEWS

DevvStream Announces Additional Investment

3 hours ago

DevvStream Boosts Carbon Offset Initiative Through E-Commerce Partnerships

1 day ago

DevvStream Accepted into Singapore Carbon Market Alliance (SCMA), Focused on Carbon Credits Aligned with Article 6

Feb 3, 2025

DevvStream Discloses Nasdaq Notice and Provides Update

Jan 28, 2025

DevvStream Launches Carbon Offset Sales Initiative Targeting Corporations and Consumers

Dec 19, 2024

DevvStream Adds Hydroelectric Power Facility to its Asia I-REC Program

Dec 18, 2024

DevvStream Enters Biogas Market via Partnership with Methane Renewable Energy Leader

Dec 12, 2024

DevvStream Enters REC Market in Asia with Medellin Solar Power Facility Partnership

Nov 29, 2024

DevvStream Provides Bi-Weekly Status Update

Nov 20, 2024

DevvStream Provides Update on Carbon Sequestration Facility Development

Nov 19, 2024

DevvStream Announces Live Investor Event to Be Held November 18, 2024

Nov 15, 2024

DevvStream Adds 2.5 Million Credits to Existing Carbon Portfolio; Announces Changes to Board of Directors

Nov 8, 2024

MANAGEMENT

Sunny Trinh

CHIEF EXECUTIVE OFFICER

As co-founder and CEO, Sunny is responsible for building and executing DevvStream’s project pipeline through his vast network of sustainable technology and corporate relationships. He has spent over 25 years in the technology sector and directly in developing new verticals in ESG and carbon markets.

He also serves as the Chief Digital Alchemist for Devvio Inc., where he develops new business models in the ESG and carbon markets.  Prior to DevvStream, Sunny led innovation as VP of Ecosystem at Avnet Inc. (AVT: NASDAQ). He was also the COO for Jooster and VP of Sales for Arrow Electronics (ARW: NYSE) where he led the design team for a Corvette driven by a quadriplegic.

Sunny served as CEO for 9:Fish Surfboards and was an adjunct professor for Cal Lutheran University’s MBA program where he started the school’s technology tract. Sunny holds a B.S. and M.E in Engineering, an M.B.A. degree, and holds several patents on electronic accessories for cell phones.

David Goertz

CHIEF FINANCIAL OFFICER

David provides accounting, assurance, taxation and business advisory services to private and public companies, not-for-profit organizations and incorporated professionals. David has specialized knowledge of the manufacturing, mining, real estate, and technology industries. He also has a keen understanding of public company operations, restructurings, acquisitions and IPOs.

Chris Merkel

CHIEF OPERATING OFFICER

Chris is the VP and Chief Operating Officer of DevvStream. Prior to joining the team, Chris spent 24 years managing strategic customers, growing technical services verticals and held sales leadership roles at Avnet (AVT: NASDAQ) and Arrow Electronics (ARW: NYSE). He has engaged with companies at every stage, from pre-funded startups to global enterprises in markets such as IIoT, consumer, industrial and medical. Additionally, Chris spent 5 years with Sierra Pacific Industries in a general sales and operations management role. He has over 30 years of sales, operations and general management experience successfully managing diverse teams and projects.

Jonathan Miller

CHIEF COMMUNICATIONS OFFICER

An accomplished communications professional with over 20 years of experience developing integrated marcom programs, Jonathan specializes in the automotive, robotics, consumer electronics, sustainability/ESG, and semiconductor domains.

With expertise in brand identity, web design, video development, copywriting, print/layout, public relations, and event management, Jonathan has held several senior positions in the Silicon Valley area, most recently with Ambarella (Nasdaq: AMBA), a leading provider of AI vision processors for edge applications. Prior to that, Jonathan was VP of Advanced Products for a consumer electronics startup whose technology patents were ultimately purchased by Facebook. He was an eighth-grade English teacher for seven years in the Oakland Unified School District and received his bachelor’s degree from Stanford University.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SIX THOUSAND USD BY LFG EQUITIES CORP FOR A ONE DAY DEVS AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

*****Sponsored by LFG Equities Corp

‍

Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments

‍
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20

Check Out the Investor Presentation HERE

Hello Everyone,

The markets are certainly choppy right now and there is a lot of uncertainty.

Investor sentiment is notably pessimistic because geopolitical tensions, trade policy uncertainties, and economic concerns.

With that being said, we can always find opportunities.

There is always an exception to the rule.

Last week while the market was blood red and getting absolutely decimated we were able to profile a 20%+ runner that was sitting under a buck.

We have a past winner back on deck for Tuesdays session and it is sitting at .80 which is right in the wheelhouse of some of our better profiles in the past few months.

We haven’t taken a look at this one in about a year but we think you should research this one thoroughly while it is sitting here under a dollar.

Pull up INDP right away.

This one has under 12 million shares in the float.

We looked at it a few times over a year ago in early 2024 and we saw it move up at much higher prices.

It is sitting here at just .80 or so right now. Make sure you keep reading.

Indaptus Therapeutics has evolved from more than a century of immunotherapy advances. The Company’s novel approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and pathways and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system-activating signals that can be administered safely intravenously (i.v.). Indaptus’ patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria producing a multiple Toll-like receptor (TLR), Nucleotide oligomerization domain (NOD)-like receptor (NLR) and Stimulator of interferon genes (STING) agonist Decoy platform. The product candidates are designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cells and pathways of innate and adaptive immunity. Decoy product candidates represent an antigen-agnostic technology that have produced single-agent activity against metastatic pancreatic and orthotopic colorectal carcinomas, single agent eradication of established antigen-expressing breast carcinoma, as well as combination-mediated eradication of established hepatocellular carcinomas, pancreatic and non-Hodgkin’s lymphomas in standard pre-clinical models, including syngeneic mouse tumors and human tumor xenografts. In pre-clinical studies tumor eradication was observed with Decoy product candidates in combination with anti-PD-1 checkpoint therapy, low-dose chemotherapy, a non-steroidal anti-inflammatory drug, or an approved, targeted antibody. Combination-based tumor eradication in pre-clinical models produced innate and adaptive immunological memory, involved activation of both innate and adaptive immune cells, and was associated with induction of innate and adaptive immune pathways in tumors after only one i.v. dose of Decoy product candidate, with associated “cold” to “hot” tumor inflammation signature transition. IND-enabling, nonclinical toxicology studies demonstrated i.v. administration without sustained induction of hallmark biomarkers of cytokine release syndromes, possibly due to passive targeting to liver, spleen, and tumor, followed by rapid elimination of the product candidate. Indaptus’ Decoy product candidates have also produced meaningful single agent activity against chronic hepatitis B virus (HBV) and chronic human immunodeficiency virus (HIV) infections in pre-clinical models.

We haven’t seen any insider selling in INDP however the CEO did put some money where his mouth is and acquired over 125k shares at significantly higher prices.

Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections, announced today that it has secured new patent approvals in China, Japan and Israel for its Decoy platform. These patents cover the use of Decoy bacteria compositions for preventing or treating Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) – two diseases that continue to pose major global health challenges. The patents also extend to combination therapies with a variety of both approved and investigational treatments.

Dr. Michael Newman, Founder and Chief Scientific Officer of Indaptus, commented, “The allowance of these patents in key international markets highlights the potential of our Decoy platform in the fight against chronic infectious diseases. With millions of people affected by HBV and HIV worldwide, expanding our intellectual property reinforces the novelty and therapeutic promise of our approach.”

A Growing Global Health Need

Chronic HBV infections remain a major health concern, especially in Asia.

• China has approximately 87 million people living with chronic HBV, nearly one-third of all cases worldwide.
• Japan has approximately 1.1 – 1.2 million people affected by chronic HBV.
• In 2022, HBV caused an estimated 1.1 million deaths worldwide, primarily due to cirrhosis and liver cancer.

Despite available treatments, new therapies are urgently needed to improve long-term outcomes.

A Unique Approach to Infectious Disease and Cancer Treatment

Preclinical studies demonstrated that Indaptus’ Decoy bacteria—which are attenuated and killed bacteria designed to stimulate the immune system—produced significant single-agent activity in standard models of chronic HBV and HIV infections.

Patented candidates from Indaptus’ Decoy platform have also produced single agent activity and durable, combination-mediated tumor eradication in multiple pre-clinical cancer models and one candidate (Decoy20) is currently being evaluated in a Phase 1 clinical trial in the U.S.for patients with advanced cancers.

With these new patents, Indaptus continues to strengthen its position as a leader in immunotherapy innovation, advancing treatments for both infectious diseases and cancer.

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial for its lead asset, Decoy20. This approval will allow the Company to expand its ongoing U.S. clinical trial, INDP-D101, to Canadian sites, broadening patient recruitment and enhancing its clinical research program. The trial will enroll patients in Canada under the current protocol, which involves weekly dosing of Decoy20. Indaptus also plans to submit an amendment to Health Canada to incorporate its upcoming combination trial, which pairs Decoy20 with Beigene’s PD-1 checkpoint inhibitor, tislelizumab.

Jeffrey Meckler, CEO of Indaptus, commented, “We are pleased to bring Canadian investigators and patients into our clinical efforts, creating a more diverse and robust data set. Health Canada’s approval followed a comprehensive review of our safety data and trial design. Expanding to Canada represents a significant step in our mission to evaluate Decoy20, a broad immune system activator, in patients with solid tumors.”

Roger Waltzman, Chief Medical Officer, added, “The addition of Canadian trial sites should allow us to accelerate the collection of valuable clinical data more efficiently, and from a broader, more diverse population. This expansion is critical as we continue to evaluate Decoy20’s unique ability to activate both the innate and adaptive immune systems, potentially addressing the challenges associated with solid tumors. By enhancing our trial infrastructure, we aim to accelerate our understanding of Decoy20’s full therapeutic potential, refine its dosing regimen, and improve treatment outcomes for patients facing difficult-to-treat cancers. We are confident this progress will pave the way for key insights that could bring us closer to meaningful advances in cancer treatment.”

SCIENCE & PIPELINE

Novel Insights. Novel Therapies.

Historically, we know that tumor regression has been observed in the presence of bacterial infection. We also know that bacteria contain immune system danger signals, called pathogen-associated molecular patterns (PAMPs), that collectively can activate all of the cellular components of our innate and adaptive immune pathways. PAMPs are recognized by receptors, such as Toll-like (TLR), NOD, STING and RIG-I, that are found on and involved in activation of many different innate and adaptive immune cells.

Our platform is based on the hypothesis that highly efficient anti-tumor immunotherapy will require safe activation of both innate and adaptive cellular immunity in both tumors and immune organs, and that this might be achieved with a multi-targeted package of bacterial PAMPs, in the form of attenuated and killed, intact but non-pathogenic bacteria delivered intravenously. While current therapies are increasingly becoming more and more personalized and costly, we are advancing an approach designed to be widely accessible, with broad anti-tumor and anti-viral activity not dependent on the targeting of specific tumor or viral antigens.

Current Approaches

Current immunotherapies only cure a very small percentage of advanced cancer patients because they activate only one or a few innate or adaptive immune cell types.

The Indaptus Approach

Goal: to safely and effectively activate both innate and adaptive cellular anti-tumor pathways by passively targeting both the tumor and  immune organs.

‍

A Unique Approach

Previous research has shown that lipopolysaccharide (LPS), an endotoxin that binds to Toll-like receptor 4 (TLR4), is a key bacterial PAMP that activates the immune system. Activated TLR4 has been shown to play a role in dendritic cell activation and T-cell-mediated anti-tumor immune responses. Our novel insights have enabled us to create attenuated and killed, non-pathogenic gram-negative bacteria with unique levels of LPS – levels that have now been shown in pre-clinical studies to be sufficient to synergize with other PAMPs in the bacteria to safely prime and/or activate innate and adaptive immune pathways. We currently have a broad patent portfolio with 34 issued or granted patents that are based on the technology originally developed by our Founder and Chief Scientific Officer, Dr. Michael Newman, at Indaptus’ predecessor company, Decoy Biosystems.

Based on our successes to date, we are now building a pipeline of therapeutic candidates designed to be delivered intravenously, targeting cancers and infectious diseases with high unmet medical needs.

Results to Date

We are currently advancing our lead candidate, Decoy20, through Phase 1 clinical trial. To date, Decoy20 and/or related candidates have demonstrated broad anti-tumor and anti-viral activity in pre-clinical models, including high percentage complete and durable anti-tumor responses in combination with different classes of existing therapeutics.

• In oncology, Decoy candidates have demonstrated the ability to eradicate established tumors in a murine model of hepatocellular carcinoma in combination with either a non-steroidal anti-inflammatory drug (NSAID) or an anti-PD-1 agent, and more efficiently with both. Tumor eradication has occurred with a wide therapeutic index and has led to induction of 100% immunological memory. In combination with low-dose chemotherapy, Decoy candidates have also produced highly efficient eradication of established tumors in a mouse model of non-Hodgkin’s Lymphoma (NHL), also with induction of immunological memory. Combination-mediated tumor eradication has also been observed with a human tumor xenograft NHL model with inclusion of a targeted antibody. Decoy candidates have also produced significant single agent activity in murine models of both metastatic pancreatic carcinoma and orthotopic, colorectal carcinoma.
• In infectious disease, single agent Decoy therapeutics have produced significantly broader activity than standard of care treatment in a pre-clinical model of chronic Hepatitis B infection, as well as single agent activity against chronic HIV infection in a pre-clinical humanized mouse model.

Generation and/or activation of the cells required for innate and adaptive anti-tumor and anti-viral immune responses takes place, to a significant extent, outside of the tumor or sites of infection, including in the spleen. Our intravenous therapeutic candidates are expected to passively target the liver, spleen, and leaky vasculature of tumors, producing immune activation in an immune organ, as well as a common site for primary and metastatic cancer and HBV infection, the liver. As our therapeutic candidates are expected to be cleared very quickly by the liver and spleen, we anticipate a low risk of non-specific autoimmune side effects relative to other types of immunotherapies designed for continuous exposure.

We have initiated our Phase 1 clinical trial of Decoy20 in December 2022 and dosed our first patient in March 2023.

‍

NEWS

Registration Is Now Open For Tribe Public’s Webinar Event “Keys To The Kingdom: Unlocking The Power Of Your Immune System” Featuring Indaptus Therapeutics’ CEO On Monday, March 17, 2025

3 days ago

Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments

Mar 4, 2025

Indaptus Therapeutics’ Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit

Feb 25, 2025

Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20

Feb 5, 2025

Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Jan 13, 2025

Indaptus Therapeutics Provides Year-End Review and Outlook for 2025

Jan 8, 2025

Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement

Nov 22, 2024

Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12, 2024

Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology

Nov 11, 2024

Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting

Nov 7, 2024‍

‍
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences

Oct 23, 2024

Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations

Oct 22, 2024

Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data

Oct 15, 2024

Indaptus Therapeutics Founder and Chief Scientific Officer to Speak on Lumanity Webinar about the Future of Innate Immunity in Cancer Immunotherapy

Oct 10, 2024

Indaptus Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Oct 8, 2024

Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses

Sep 5, 2024

Indaptus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 3, 2024

Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12, 2024

Indaptus Therapeutics, Inc. Announces $3.0 Million Registered Direct Offering and Concurrent Private Placement

Aug 7, 2024

Indaptus Therapeutics to Present Positive Data on Lead Product Candidate, Decoy20, at STING & TLR-Targeted Therapies Summit

Jun 11, 2024

‍

MANAGEMENT TEAM

JEFFREY A. MECKLER

Chief Executive Officer

Jeffrey Meckler currently serves as our Chief Executive Officer, bringing more than 30 years of financial and healthcare leadership experience to the company. Most recently, Jeff was the CEO of Intec Pharma, and prior to that, CEO of Cocrystal Pharma, transforming it from a research company into a clinical and development company. Earlier in his career, Jeff was managing director of the Andra Group, a life sciences consulting firm, and acted as a director and interim CEO of Cypress Bioscience after its acquisition by Royalty Pharma. Jeff started his career at Pfizer, where he held a series of positions in manufacturing systems, market research, business development, strategic planning and corporate finance, which included playing a significant role in acquisitions and divestitures. He has also served as a director of QLT, Inc., Cocrystal Pharma, ClearFarma USA, Kyalin Bioscience, and Alveolus, and currently serves as director of Travere Therapeutics, where he also previously served as Chairman. Jeff is the past President and continues to serve on the Board of Children of Bellevue, a non-profit organization focused on advocating and developing pediatric programs at Bellevue Hospital Center. He holds a B.S. in industrial management, an M.S. in industrial administration from the Tepper School of Business at Carnegie Mellon University, and a J.D. from Fordham University’s School of Law.

MICHAEL J. NEWMAN, PH.D.

Founder and Chief Scientific Officer

A founder of the company, Dr. Michael Newman currently serves as our Chief Scientific Officer. Most recently, he was Founder and CEO of Decoy Biosystems, where he developed the technology that serves as the foundation of Indaptus. With more than 35 years of experience carrying out and managing oncology drug discovery through early development in academia and at pharmaceutical and biotechnology companies, Michael has also served as a consultant to ~35 companies, assisting with target identification and prioritization, management of R&D, fundraising, and in/out-licensing. His previous positions include faculty appointments in biochemistry at Brandeis University and the Roche Institute of Molecular Biology, Senior Associate Director of Oncology at Sandoz Pharmaceuticals (world-wide head of Cancer Biology), Executive Director of Oncology at Novartis Pharmaceuticals (Head of Cancer Biology in the U.S.), and senior management positions at several Biotechnology companies, where he also managed drug discovery programs in inflammation, diabetes, and infectious disease. Michael received a Bachelor’s degree in biology from the University of California at San Diego, a Ph.D. in cell and developmental biology from Harvard Medical School (National Science Foundation Pre-doctoral Fellow) and carried out post-doctoral research at Cornell University.

WALT A. LINSCOTT

Chief Operating Officer

Walt Linscott brings more than three decades of global leadership, entrepreneurial and professional experience with broad business development, operational, regulatory, and transactional experience in the Life Sciences sector to his current role as Chief Operating Officer at Indaptus. Most recently, he held the position of Chief Business Officer at the company. Prior to Indaptus he was the Chief Business Officer at Intec Pharma. He is also a Founding executive member of Oxford Strategic Alliance, a multinational business development and referral enterprise for strategic advice, management and investment development/management for individuals and companies that are globalizing. Previously, Walt served as President, COO and General Counsel at Treiber Therapeutics, an anti-viral-focused venture he co-founded. He has also served in a variety of General Counsel and Corporate Secretary roles at Cocrystal Pharma, Carestream Health, and Solvay Pharmaceuticals, where he also led compliance, IP, security, privacy, public affairs and government affairs functions. In addition, he was previously an Associate and Partner at Thompson Hine where he founded the firm’s Atlanta office, served as Partner in Charge, and as Chair of the firm’s Life Science Practice Group. Walt holds a Master of Science in Experimental and Translational Therapeutics with honors from the University of Oxford, a Master’s degree in Global Business from the University of Oxford and Master’s degree in Entrepreneurship from Cambridge University. He earned his J.D. from the University of Dayton School of Law where he served as Managing Editor of the Law Review. After graduating with a Bachelor’s degree from Syracuse University and prior to entering law school, he earned a commission and served on active duty as an Officer in the United States Marine Corps. Walt is also a Certified Flight Instructor and was previously a professional stunt pilot.

ROGER J. WALTZMAN

Chief Medical Officer

Roger Waltzman, M.D., M.B.A. currently serves as our Chief Medical Officer. Dr. Waltzman is a board-certified medical oncologist whose career highlights include the roll of Chief Medical Officer of publicly traded company, Molecular Templates (2019-2023) and multiple senior drug development roles at Novartis Oncology (2007–2013), where he played a leading role in the development of imatinib, nilotinib, and ruxolitinib. From 2013 to 2016, Dr. Waltzman was the Full Development Head of Malaria Drug Development at Novartis. More recently, Dr. Waltzman was CMO at Rgenix (now Inspirna), where he supervised the development of immuno-oncology and metabolic inhibitor assets through Phase 1 a/b. Previously, he served as CSO at Jaguar Health and Napo Pharmaceuticals, where he led scientific aspects of development and commercialization of Mytesi® (crofelemer).

Before joining the industry, Dr. Waltzman held assistant professorships in medical oncology and palliative care at Saint Vincent’s Hospital and Mount Sinai School of Medicine in New York. He completed his fellowship in hematology/oncology at Memorial Sloan Kettering Cancer Center. Dr. Waltzman earned a Master of Business Administration at Columbia Business School and a Doctor of Medicine and Bachelor of Arts from Brown University.

NIR SASSI

Chief Financial Officer

Nir Sassi currently serves as our Chief Financial Officer, bringing a broad skillset across management, corporate finance, due diligence, accounting, and financial analysis. Prior to joining Indaptus, Nir spent 11 years at Intec Pharma, starting as Vice President of Finance and ending his tenure there as Chief Financial Officer. Previous to that, Nir served as a Senior Manager at PricewaterhouseCoopers Israel for eight years, including two years relocation to the PWC New York office. He is a certified public accountant in Israel and holds a Bachelor’s degree in economics and accounting from Ben Gurion University in Beer Sheva, Israel.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIVE THOUSAND SEVEN HUNDRED FIFTY USD BY LFG EQUITIES CORP FOR A ONE DAY INDP AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

**** Sponsored by LFG EQUITIES CORP

SYTA announced the launch of the Siyata SD7, a purpose-built, mission-critical push-to-talk device

Siyata Mobile Signs Definitive Agreement to Merge with Leading AI Gaming Developer, Core Gaming, a company with unaudited gross revenues of approximately $80 million

READ THE COMPANY PRESENTATION HERE

___________________________

Hello Everyone,

We have another profile for Tuesdays session.

This is a company that we haven’t taken a look at in quite some time.

Pull up SYTA immediately.

This one just had a reverse split right before the first of the year.

The shares out are just around 2M post split, putting the market cap at around 5M.

Need I say more?

Siyata Mobile Inc. (NASDAQ: SYTA) is a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

However, in a significant diversification effort, Siyata is merging with Core Gaming, a leading AI-driven mobile gaming developer. Core Gaming is valued at $160 million and reported $80 million in unaudited revenue. The AI gaming company operates over 2,000 mobile games globally with approximately 40 million monthly active users. This move positions Siyata strategically within the rapidly expanding mobile gaming market.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world’s first 3G connected vehicle device as well as the world’s first 4G/LTE vehicle-mounted smartphone for First Responders and commercial fleets and vehicles, thereby creating a new category in the cellular device market with a dedicated smartphone tailor-made for the commercial vehicle market.

Siyata’s suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company’s flagship product, the Uniden UV350, is the world’s first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada’s largest LTE network and PTT community, as well as AT&T in the U.S. Further expanding its availability, Siyata is completing network approval with another U.S. Tier 1 operator to launch the UV350 in Q3 2019.

Despite Siyata’s small size, no other competitor offers as comprehensive of a portfolio of products. Siyata Mobile Inc. (Nasdaq: SYTA) provides disruptive solutions aimed at the Push-to-talk-over-Cellular (PoC) industry, with three complementary product categories targeted to the same core channels and customers. Large global telecommunications customers provide potential rapid entry into a $50 billion North American market.

Siyata Mobile Signs Definitive Agreement to Merge with Leading AI Gaming Developer, Core Gaming

VANCOUVER, BC, Feb. 26, 2025 /PRNewswire/ — Siyata Mobile Inc. (Nasdaq: SYTA) (“Siyata” or the “Company”), a global developer and vendor of Push-to-Talk over Cellular (PoC) handsets and accessories, today announced that the Company has signed a definitive merger agreement with Core Gaming, Inc. (“Core Gaming”) a privately-held, global gaming developer and publisher with approximately $80 million in revenues in 2024.

Key Highlights of the Merger:

• Core Gaming, Inc., a Delaware corporation, will become a wholly owned subsidiary of Siyata through a merger with a subsidiary of Siyata.
• The combined public company will be led by Mr. Aitan Zacharin, the current CEO of Core Gaming.
• Marc Seelenfreund, the current CEO of Siyata, will step down as the public company CEO to serve as President and lead a newly formed Push-To-Talk subsidiary of Siyata.
• The Board of Directors of the combined public company will consist of Marc Seelenfreundand four directors designated by Core Gaming.
• In exchange for the outstanding shares of Core Gaming, Siyata will issue common shares to the shareholders of Core Gaming based on an exchange ratio calculated as $160,000,000 divided by the volume-weighted average closing price (VWAP) of Siyata’s common shares on the Nasdaq Stock Market LLC for the 10-day trading period immediately preceding the effective time of the merger.
• Legacy Siyata shareholders shall have the right to receive a stock dividend within six months after the merger so that they will own a minimum of 10% of the combined entity.
• The Board of Directors of Siyata received a fairness opinion from ValueScope, LLC., a Marshall & Stevens company, valuing Core Gaming at $160 million.

Marc Seelenfreund, CEO of Siyata, commented, “Today’s announcement is the product of an exhaustive assessment of numerous strategic alternatives for Siyata over the past several months. Core Gaming possesses all of the qualities we look for in a merger partner – strong business fundamentals, excellent management and opportunities for outsized growth. We could not be more excited to partner with Core Gaming and unlock value for our shareholders. The timing of this transaction is significant given the positive outlook for Core Gaming’s business. Core Gaming operates in the fast-growing mobile gaming industry and we believe is well-positioned for rapid growth in the near-term. It has been independently valued at approximately $160 million, which will provide Siyata’s shareholders with a premium to our current market valuation.”

Mr. Seelenfreund continued, “At Siyata, we remain committed to our mission of being a leader in critical communications, providing outstanding service to our customers and ensuring a seamless transition for our partners. We have made great progress towards expanding distribution and increasing sales, and we are highly optimistic about the future of this business. Despite our many successes, we believe that the company is undervalued, and the merger with Core Gaming represents an exciting path forward. I am pleased to remain with Siyata to continue to lead our efforts and further our strategic objectives.”

Core Gaming’s Business Profile:

• Core Gaming is an international gaming developer and publisher that has developed, published and marketed over 2,000 casual mobile games in over 140 countries.
• Core Gaming engages 40 million monthly active users, and has an extensive worldwide distribution platform, which has led to over 600 million downloads.
• Core Gaming has a unique, algorithm-driven technology that gives it an edge in user acquisition.
• Core Gaming has developed cutting edge AI tools using text, language, image and video models to achieve a 50% boost in content production, reducing production time by over 40%, and significantly enhancing creative output and efficiency.
• In fiscal year 2024, Core Gaming had unaudited gross revenues of approximately $80 million.

Aitan Zacharin, CEO of Core Gaming, commented, “We are excited to announce this reverse-merger with Siyata as it provides us with the opportunity to become a publicly traded company at a pivotal time in our industry. We believe that Core Gaming is well positioned to enter the public markets to pursue our vision of becoming a leading AI-driven gaming company in what is now a $126 billion global market1. We are beginning to see how our AI tools and algorithms are shaping the next generation of gaming. Our unique technology coupled with our exceptional team puts us on track for significant growth potential. I look forward to working with Marc and his team to finalize the transaction, and to make this a tremendous success for Siyata shareholders.”  

The Board of Directors of both Siyata and Core Gaming have unanimously approved the proposed transaction, which is expected to be completed in the second quarter of 2025, subject to regulatory approval and the satisfaction of customary closing conditions in the merger agreement. For further information regarding the terms and conditions contained in the definitive Agreement, please see Siyata’s Current Report on Form 6-K to be filed with the U.S. Securities and Exchange Commission.

The Company plans to hold a virtual press conference today at 4:05pm ET to discuss the merger. The event can be viewed on the Siyata Investor Relations website, or by clicking this link.

About Core Gaming

Core Gaming is an international AI driven mobile games developer and publisher headquartered in Miami. We create entertaining games for millions of players worldwide, while empowering other developers to deliver player-focused apps and games to enthusiasts. Core’s mission is to be the leading global AI driven gaming company. Since our launch we have developed and co-developed over 2,000 games, driven over 600 million downloads, and generated a global footprint of over 40 million users from over 140 countries.

Siyata Mobile SD7 Mission Critical Push to Talk Over Cellular Device Featured

UScellular Keeps Business and Government Customers Connected with Intuitive Mission Critical Push to Talk Solution

“Siyata’s SD7 rugged Mission Critical Push to Talk over cellular radio handset is an industry leading device that offers UScellular business customers an alternative to land-mobile radios,” By Kim Kerr, senior vice president, enterprise sales and operations for UScellular.

While State And Local Budgets Experience A Squeeze, Siyata Mobile Provides Police With Affordable And Modern Communication Technology

Siyata’s unique approach of offering an affordable mission-critical PTT over Cellular handset that looks and operates like a two-way radio may allow first responder agencies to equip more of their staff than ever before with a reliable and easy-to-use handset to keep more staff connected. With a track record as a pioneer in the industry and with solutions catering to various uses in areas with and without strong cellular coverage, Siyata has earned a solid reputation for reliability and versatility. With rising budget cuts, this maybe solution that state and local governments are looking for.

As a leading developer and distributor of cutting-edge Mission Critical Push to Talk Over Cellular (PoC) devices, including its flagship products, the SD7 Handset and VK7 Vehicle Kit, Siyata is aiming to revolutionize the way industries worldwide connect and collaborate.

In a rapidly evolving landscape, the SD7 Handset stands out to us as the pinnacle of next-generation communication solutions. Designed to seamlessly integrate with existing systems while offering unparalleled functionality, the SD7 stands to bridge the gap between traditional two-way radios and modern cellular networks. Its reportedly rugged design, military-standard durability, and nationwide coverage is designed to ensure reliability and effectiveness across various verticals, from first responders to construction teams.

Complementing the SD7 is Siyata’s innovative VK7 Vehicle Kit, working to transform any vehicle into a mobile communication hub. With its reportedly seamless integration, robust features, and reliable connectivity, the VK7 is designed to enhance safety and efficiency for commercial fleets, emergency responders, and more.

According to Siyata Mobile, it’s not just disrupting the market; it’s setting new standards for communication excellence. With a track record of exponential growth, a strong presence in key global markets, and a visionary leadership team, we see this as an attractive investment for investors interested in the future of communication technology

Top Reason to have SYTA on your radar

• Market Disruption: Siyata Mobile (NASDAQ: SYTA) is poised to disrupt the multi-billion-dollar Land Mobile Radio (LMR) industry with its cutting-edge Mission Critical Push to Talk Over Cellular (PoC) technology
• Next-Gen Communication: With the SD7 and VK7, Siyata offers next-generation communication solutions that bridge the gap between traditional two-way radios and modern cellular networks.
• Innovative In-Vehicle Solutions: The VK7 Vehicle Kit is designed to transform any vehicle into a mobile communication hub, enhancing safety and efficiency for commercial fleets and emergency responders
• Global Reach: Siyata operates in key geographies including the United States, Canada, Europe, Australia, and the Middle East, offering solutions tailored to diverse market needs.
• Rapid Industry Growth: The Mission Critical Push to Talk Over Cellular (PoC) industry is experiencing rapid growth, with a forecasted global PoC growth of approximately 9.4% CAGR, reaching approximately $6.95 billion by 2027
• Strong Market Position: With a full-year 2023 revenue of $8.2 million, up 27% year-over-year, Siyata demonstrates its ability to capture market share and deliver consistent growth.
• Comprehensive Product Portfolio: From rugged handsets to in-vehicle devices, Siyata offers a comprehensive product portfolio to cater to the communication needs of various industries, including first responders, hospitals, schools, security, construction, and hospitality
• Visionary Leadership: Led by CEO Marc Seelenfreund and a seasoned management team, Siyata is guided by a vision of innovation, excellence, and market leadership in communication technology
• High Growth Earnings: SYTA is expected to become profitable in the coming quarters.
• High Growth Revenue: SYTA’s revenue is forecast to grow dramtically in 2024 and beyond

Siyata Mobile, Ambra Solutions And TASSTA Americas Collaborate To Migrate Mining Sites To Cutting-Edge Wireless Networks For All Their Communication Needshttps://t.co/zCfWoQoEXY#SiyataMobile #PoC #PublicSafety #Logistics #InstantCommunication #TwoWayCommunication #PushToTalk pic.twitter.com/oo9rxx7jC4

— Siyata (@SiyataStories) November 5, 2024

SD7: A Game-Changer in Mission Critical Push to Talk Over Cellular Technology!

SIYATA SD7

Siyata Specializes in Rugged PTT Handsets: SD7 is its Next Generation PoC Handset Complementing its Portfolio of Disruptive Handsets

THE SD7 IS A GAME CHANGER

A Perfect Upgrade from land mobile radio (LMR):

• forwardA simple, purpose built, highly functional and rugged Android-based PTT only handset
• forwardRugged IP68 rated design protects against dust and debris
• forwardExcellent sound quality allowing for clear communication in the presence of background noise
• forwardAll the benefits of PoC without the headaches of managing the current generation of rugged smartphones and feature phones
• forwardRobust Next Gen 5G product portfolio coming

‍

‍

‍

NEWS

24/7 Market News Updates Its Siyata Mobile Investor Page Following Core Gaming AI Merger News

5 days ago

Siyata Mobile Provides Additional Commentary Regarding the Terms of Its Proposed Merger with Core Gaming

Feb 28, 2025

Siyata Mobile Signs Definitive Agreement to Merge with Leading AI Gaming Developer, Core Gaming

Feb 26, 2025

Siyata Mobile’s SD7 ULTRA to be Offered as Part of T-Mobile’s 5G Ecosystem for First Responders

Feb 25, 2025

Siyata Mobile Further Expands Distribution in New Agreement with IP Access International

Feb 24, 2025

247 Market News: Siyata Mobile Named by T-Mobile as a Key Partner in T-Priority 5G First Responder Initiative

Feb 21, 2025

MicroCap Reports Discusses Game-Changing Partnership in Push-to-Talk Communications

Feb 19, 2025

MicroCap Reports Issues Update on Siyata Mobile, Inc.

Feb 13, 2025

Siyata Mobile Announces New Order from Leading Canadian Gaming and Entertainment Company

Feb 13, 2025

24/7 Market News Commentary on Direct-to-Cell Satellite Connectivity Service and Siyata Mobile

Feb 11, 2025‍
24/7 Market News Covers the PTT Market’s Rapid Growth Rate Featuring Siyata Mobile

Feb 7, 2025

24/7 Market News Memo: Siyata Mobile to Implement Domestic PTT Device Manufacturing Program

Feb 4, 2025

Siyata Mobile Provides Update on Upcoming Press Conference

Feb 3, 2025

24/7 Market News Reminder: Siyata Mobile will Host Groundbreaking Shareholder Wealth Creation Event

Jan 29, 2025

Siyata Mobile Announces New Order from Major U.S. Transit Authority

Jan 28, 2025

24/7 Market News Publishes Editorial Regarding Siyata Mobile’s Agreement with Global Electronics Icon, JVC Kenwood, and Upcoming Pivotal Corporate Milestone

Jan 15, 2025

Siyata Mobile Provides Business Update

Jan 14, 2025

Siyata Mobile Seizing Strategic Market Opportunities

Jan 8, 2025

Siyata Announces Reverse Stock Split

Dec 24, 2024

24/7 Market News Publishes Editorial Featuring Siyata Mobile’s Upcoming Press Event to Unveil Pivotal Corporate Milestone

Dec 19, 2024

‍

MANAGEMENT TEAM

Marc Seelenfreund – CEO

Founder and CEO of Siyata . Prior to establishing Siyata Mr. Seelenfreund was a VP at Sunrise Corporation in New York focusing on financing publicly traded technology companies. Mr. Seelenfreund has a law degree and is a board member at a leading private university.

Gerald Bernstein – CFO

Mr. Bernstein spend 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. Mr. Bernstein holds a Bachelor of Commerce as well as a Graduate Diploma in Public Accountancy- both from McGill University. Member of the Canadian Institute of Chartered Accountants since 1987 and a professional chartered accountant.

Glenn Kennedy – VP Sales

Mr. Kennedy has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Mr. Kennedy has managed sales nationally for Motorola Canada, HTC Communications Canada and Sonim Technologies. Mr. Kennedy holds an Bachelor of Arts in Honors Business Administration from the Richard Ivey School of Business at the University of Western Ontario

GARY HERMAN – Chairman of the Board

Mr. Herman has several decades of experience as a sophisticated public company investor, fund manager and investment banker. Over the course of his career, he has served on both public and private company boards of directors and has also been a corporate officer, capital raiser, and restructuring specialist.
Mr. Herman currently serves on the Board of Jupiter Wellness, Inc. (NASDAQ: JUPW); XS Financial, Inc. (CSE: XS), and SusGlobal Energy Corp. (OTCQB: SNRG).

Stephen Ospalak, Board Member

Over 20 years in telecom, currently SVP Marketing & Operations at BMG Inc. Served as interim CEO for AiTelecom; Global Integration Officer for Virgin Management Inc.; Canadian VP & Board Advisor for Brightstar, and as SVP Operations at Iusacell. Served as VP of Products & Services at Telus Communications Inc. responsible for an annual spend > $US 1billion in wireless & wireline equipment. Led the planning and execution of Clearnet’s market debut and nationwide launch of the iDEN and PCS Cellular services, setting the North American PCS launch record. Held management positions at AT&T.

Lourdes Felix, Board Member

Lourdes Felix is a corporate finance executive offering over fifteen years of combined experience in public accounting and in the private sector in building, leading, and advising corporations through complex restructurings. Ms. Felix was previously the controller for a mid-size public accounting firm for over seven years and was responsible for the operations and financial management of regional offices. Ms. Felix has been a Director of BioCorRx Inc. since March 7, 2013. Ms. Felix was appointed Chief Executive Officer of BioCorRx on November 9, 2020 and became Chief Financial Officer of BioCorRx on October 1, 2012. Ms. Felix was President of BioCorRx from February 26, 2020 until she resigned upon her appointment as CEO on November 9, 2020. Ms. Felix holds a Bachelor of Science degree in Business Management and Accounting from University of Phoenix.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SEVEN THOUSAND USD BY LFG EQUITIES CORP FOR A ONE DAY SYTA AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

‍

*****SPONSORED BY ADOBE GLOBAL, LLC

‍

Clean Energy Technologies, Inc. Announces a Strategic Partnership with METIS Power to Provide Advanced Microgrid Solutions for AI Data Centers and Cryptocurrency Miners

Clean Energy Technologies, Inc. Signs Memorandum of Understanding with Freyr Technology Pte. Ltd. to Deliver AI Computing and Data Center Services

‍

_________________________

Hello Everyone,

We have another action packed week ahead.

This next one has incredible bounce potential from its current levels.

Pull up CETY immediately and put it on your screen.

Headquarter in Irvine, California, Clean Energy Technologies is a rising industry leader in the zero-emission revolution, providing eco-friendly energy solutions, clean energy fuels, and alternative electric power for small to mid-sized projects across North America, Europe, and Asia.

The company harnesses the power of heat and biomass to produce electricity with zero emissions and minimal cost, with a focus on delivering Waste Heat Recovery Solutions that utilize its patented Clean Cycle TM generator.

Additionally, the company offers Waste to Energy Solutions, converting into electricity, renewable natural gas, hydrogen, and BioChar. Clean Energy Technologies also provides Engineering, Consulting, and Project Management services, leveraging its expertise to develop clean energy projects for both municipal and industrial customers, as well as Engineering, Procurement and Construction (EPC) companies.

Furthermore, the company operates in Natural Gas (NG) trading in China, sourcing and supplying natural gas to industries and municipalities across the country. CETY is establishing a marketplace in China and Asia with the aim of promoting its products and solutions to tap into the scalable and lucrative Asian markets through cross-selling. With a relentless focus on innovative and cutting-edge solutions, Clean Energy Technologies, Inc. is committed to driving the clean energy industry forward and promoting a sustainable future.

Waste to Energy

Waste, disposal, transport, and/or storage of the same has long been a challenge and now it is becoming increasingly expensive. There are now large systems implemented to eliminate waste at the storage locations in many large cities. CETY brings a solution to market that allows the producers to eliminate the disposal and transport costs before shipping waste to a large collection facility, while producing value added products.

Originally designed to fix the shortcomings of other Pyrolysis systems, the HTAP products use high temperature ablative decomposition to reduce the waste containing complex hydrocarbon chains into Hydrogen, methane, and other Syngas components and into biochar. This flash decomposition system eliminates the hard to handle and dispose of tars common to other Pyrolysis systems.

HTAP 5 and HTAP 10 allow for modular design and installation of a solution to handle 5,000 and 10,000 tons annually of any carbonic waste stream. These solutions handle dryer agricultural waste that digesters do not want. They accommodate woodchips, plastics, tires, and many other waste streams and convert that waste to sellable products: electricity, green hydrogen and syngas, and biochar.

We have had tremendous success as of late with our bounce profiles. Checkout the chart on the one.

‍

Clean Energy Technologies, Inc. Announces a Strategic Partnership with METIS Power to Provide Advanced Microgrid Solutions for AI Data Centers and Cryptocurrency Miners

IRVINE, CA., Nov. 21, 2024 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (Nasdaq: CETY) (the “Company” or “CETY”), a clean energy manufacturing and engineering, procurement, and construction (EPC) services company, offering eco-friendly green energy solutions, clean energy fuels, and alternative electric power for small and mid-size projects in North America, Europe, and Asia, is pleased to announce a strategic partnership with METIS Power to develop advanced microgrid solutions for AI data centers and cryptocurrency mining operations.

METIS Power Inc., a prominent player in the energy sector, specializes in providing scalable and efficient energy systems. The power generation and energy storage solutions offered by METIS Power integrates CETY’s microgrid solutions to support data centers. CETY’s solutions integrates waste heat recovery system and utilizes wasted heat from natural gas turbines to power chillers, effectively reducing costs associated with cooling. With this collaboration, CETY can address the increasing energy demands of AI data centers and cryptocurrency mining operations by providing innovative, reliable, and sustainable microgrid solutions. “We are excited to partner with METIS Power to bring cutting-edge microgrid solutions to AI data centers and crypto miners,” said Kam Mahdi, CEO of Clean Energy Technologies, Inc. “This partnership aligns with our mission to provide sustainable energy solutions that not only meet the high energy demands of these industries but also promote reliability, flexibility, and sustainability.”

Microgrids are vital for ensuring a stable and resilient power supply, especially for energy-intensive operations like AI data centers and crypto-mining. These localized energy systems can operate independently or in conjunction with the main grid, providing greater reliability and flexibility. By leveraging METIS Power’s expertise in power generation and energy storage and CETY’s microgrid solutions the partnership will deliver customized microgrid solutions that optimize energy use, enhance efficiency, reduce operational costs, increase uptime, and significantly minimize carbon footprints.

About METIS Power Inc.: METIS Power is a leading provider of power generation and energy storage solutions, specializing in the design and implementation of sustainable and efficient energy systems. METIS Power is committed to leveraging cutting-edge technologies and responsible practices to meet the fast growing energy demands while fostering a greener and resilient future.

For more information, visit https://metispower.com

For additional information about METIS Power’s data center solution, visit this page

Follow METIS Power on our social media: X | LinkedIn | YouTube

Clean Energy Technologies, Inc. Signs Memorandum of Understanding with Freyr Technology Pte. Ltd. to Deliver AI Computing and Data Center Services

Irvine, CA., Nov. 12, 2024 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (“CETY”) (Nasdaq: CETY), a clean energy manufacturing and services company offering eco-friendly green energy solutions, clean energy fuels, and alternative electric power for small and mid-size projects in North America, Europe, and Asia, has signed a memorandum of understanding with Freyr Technology Pte. Ltd. (Freyr) to deliver AI Computing and Data Center services in Southeast Asia.

Freyr is the Preferred Partner of NVIDIA, focusing on developing enhanced technical solutions to optimize the Model Flop Utilization (MFU) of NVIDIA’s GPU for its clients.

In response to the growing market demand for AI Computing and Data Center services, CETY and Freyr will collaborate to fulfill this demand for potential clients. Freyr will take the lead in signing new clients and operating the Data Centers, while CETY will support the initiative by providing NVIDIA infrastructure required by Data Center services, along with marketing and sales efforts globally.

CETY can leverage this collaboration to cross-sell its clean energy solutions to AI Data Centers. By applying CETY’s expertise in energy efficiency, the partnership aims to reduce the operational costs of Data Centers.

About Clean Energy Technologies, Inc. (CETY)

Headquartered in Irvine, California, Clean Energy Technologies, Inc. (CETY) is a rising leader in the zero-emission revolution by offering eco-friendly green energy solutions, clean energy fuels and alternative electric power for small and mid-sized projects in North America, Europe, and Asia. We deliver power from heat and biomass with zero emission and low cost. The Company’s principal products are Waste Heat Recovery Solutions using our patented Clean CycleTM generator to create electricity. Waste to Energy Solutions convert waste products created in manufacturing, agriculture, wastewater treatment plants and other industries to electricity and BioChar. Engineering, Consulting and Project Management Solutions provide expertise and experience in developing clean energy projects for municipal and industrial customers and Engineering, Procurement and Construction (EPC) companies.

‍

NEWS

Clean Energy Technologies, Inc. Announces a Strategic Partnership with METIS Power to Provide Advanced Microgrid Solutions for AI Data Centers and Cryptocurrency Miners

Nov 21, 2024

Clean Energy Technologies, Inc. Signs Memorandum of Understanding with Freyr Technology Pte. Ltd. to Deliver AI Computing and Data Center Services

Nov 12, 2024

Clean Energy Technologies, Inc. Plans to Expand into Cryptocurrency Mining and Artificial Intelligence Datacenter Sectors

Nov 6, 2024

Clean Energy Technologies, Inc. and Exergy International Sign MOU to Promote ORC Heat Recovery Solutions Across the Americas

Oct 29, 2024

Clean Energy Technologies, Inc. Collaborates with True North Computing to Deliver Advanced Microgrid Solutions for Cryptocurrency Mining Operations

Oct 8, 2024

Clean Energy Technologies, Inc. Affiliate Vermont Renewable Gas Secures $1M USDA REAP Grant to Advance Biomass Solutions and Waste-to-Energy Technologies

Oct 7, 2024

CETY CEO KAM MAHDI ADDRESSES GOVERNMENT AND BUSINESS LEADERS AT FORUM FOR LATVIA PRESIDENT EDGARS RINKĒVIČS’ ECONOMIC DELEGATION TO CALIFORNIA

Sep 26, 2024

Clean Energy Technologies, Inc. Expands Waste Heat to Power Operations to Brazil Through Strategic Partnership with Green Energy Ventures

Aug 14, 2024

Clean Energy Technologies, Inc. CEO joins California-Latvia economic development and cross-sector cooperation delegation; addresses business forum

Aug 6, 2024

Clean Energy Technologies, Inc. Affiliate Receives Air Quality Permit from the Vermont Department of Environmental Conservation.

Jun 25, 2024

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SEVEN THOUSAND USD BY ADOBE GLOBAL LLC FOR A ONE DAY CETY AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

********SPONSORED BY LFG EQUITIES CORP.

‍

Net Revenue: R$92.2 million ($15.7 million), a 12.5% increase compared to R$81.9 million in H1 2023

Nvni Group Limited reports 2023 FY results: Net Revenue growth of 36%, Adjusted EBITDA up 142%

2023 Revenues Which Were Just Reported in December were Roughly $23 Million

_________________________

Hello Everyone,

We have a very interesting profile for you to take a look at before the bell tomorrow.

This one is EXTREMELY volatile right now but if timed right could prove to be the mother of all bounce plays.

Pull up NVNI right now.

There is no way to sugar coat this one. It has taken a beating this month.

It was up over 6 bucks earlier this month but it was sitting at the same levels as now back in December.

There has been some serious volatility in this one over the past few months.

Look at that chart and look how much this one has been beat down.

We are going to be watching this one close at the open to see which way it is heading but when this one bounces it could be massive given all the short interest on th way down.

We just have to wait and see what the morning brings.

Nuvini Group Limited Reports Strong Growth in First Half 2024 Results

Adjusted EBITDA Up 25%, Operating Profitability Shows Significant Improvement

NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) — Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private SaaS B2B companies in Latin America, today announced its unaudited financial results for the first half of 2024, reflecting continued revenue growth, operational efficiencies, and financial resilience. The company will file a 6-K with the SEC today.

Key Financial Highlights:

• Operating Profit: R$14.2 million, a dramatic increase from R$0.3 million in the prior year period, demonstrating improved operational efficiencies and cost management.
• Adjusted EBITDA: R$26.5 million, a 25% increase from R$21.2 million in H1 2023, reflecting improved profitability and disciplined cost control.
• Net Revenue: R$92.2 million, a 12.5% increase compared to R$81.9 million in H1 2023.
• Net Cash from Operating Activities: R$16.3 million, further reinforcing the Company’s ability to generate strong cash flow from its growing operations.

“Nuvini’s H1 2024 results showcase our ability to drive sustainable growth and optimize operational performance,” said Pierre Schurmann, CEO of Nuvini. “We have made significant strides in improving profitability while continuing to expand our revenue base. Our disciplined acquisition strategy and operational enhancements are positioning Nuvini as a leader in the Latin American SaaS market.”

Operational and Strategic Highlights:

• Revenue Growth Across Portfolio: Increased customer retention and a growing client base contributed to the double-digit revenue growth.
• Improved Cost Management: Sales and marketing expenses decreased by 11.6%, demonstrating greater efficiency in customer acquisition.
• Enhanced Cash Flow: The Company’s strong net cash from operations of R$16.3 million further solidifies its ability to fund future growth initiatives.
• Technology and Product Enhancements: Continued investments in AI-driven solutions and platform improvements, aimed at delivering enhanced value to customers.

Nuvini Group Limited Reports Strong Growth in First Half 2024 Results

Adjusted EBITDA Up 25%, Operating Profitability Shows Significant Improvement

NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) — Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private SaaS B2B companies in Latin America, today announced its unaudited financial results for the first half of 2024, reflecting continued revenue growth, operational efficiencies, and financial resilience. The company will file a 6-K with the SEC today.

Key Financial Highlights:

• Operating Profit: R$14.2 million, a dramatic increase from R$0.3 million in the prior year period, demonstrating improved operational efficiencies and cost management.
• Adjusted EBITDA: R$26.5 million, a 25% increase from R$21.2 million in H1 2023, reflecting improved profitability and disciplined cost control.
• Net Revenue: R$92.2 million, a 12.5% increase compared to R$81.9 million in H1 2023.
• Net Cash from Operating Activities: R$16.3 million, further reinforcing the Company’s ability to generate strong cash flow from its growing operations.

“Nuvini’s H1 2024 results showcase our ability to drive sustainable growth and optimize operational performance,” said Pierre Schurmann, CEO of Nuvini. “We have made significant strides in improving profitability while continuing to expand our revenue base. Our disciplined acquisition strategy and operational enhancements are positioning Nuvini as a leader in the Latin American SaaS market.”

Operational and Strategic Highlights:

• Revenue Growth Across Portfolio: Increased customer retention and a growing client base contributed to the double-digit revenue growth.
• Improved Cost Management: Sales and marketing expenses decreased by 11.6%, demonstrating greater efficiency in customer acquisition.
• Enhanced Cash Flow: The Company’s strong net cash from operations of R$16.3 million further solidifies its ability to fund future growth initiatives.
• Technology and Product Enhancements: Continued investments in AI-driven solutions and platform improvements, aimed at delivering enhanced value to customers.

‍

NEWS

Nuvini Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements

Jan 23, 2025

NVNI Group Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(2)

Jan 15, 2025

Nvni Group Limited reports 2023 FY results: Net Revenue growth of 36%, Adjusted EBITDA up 142%

Dec 26, 2024

Nuvini (Nasdaq: NVNI) Announces Aaron Ross as Board Adviser

Nov 18, 2024

Nvni Group Limited Receives Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

Nov 15, 2024

Nvni Group Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Nov 7, 2024

Nuvini Announces Successful Financing Round and Appointment of New Chief Operating Officer

Nov 6, 2024

Nuvini (Nasdaq: NVNI) Announces José Mário Ribeiro Jr as Board Adviser

Aug 9, 2024

Nuvini (Nasdaq: NVNI) joins Russell 3000E Index

Jul 22, 2024

Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Filing

May 17, 2024

‍

MANAGEMENT

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SIX THOUSAND TWO HUNDRED FIFTY USD BY LFG EQUITIES CORP FOR A ONE DAY NVNI AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

****Sponsored By Sideways Frequency, LLC

‍

Atlas Lithium’s Plant Is Now En Route to Brazil – Marking Major Milestone Towards Production

CHECK OUT THE INVESTOR PRESENTATION HERE ‍

_________________________

Hello Everyone,

Wow, what another crazy session today was.

It exploded up almost 30% and hit highs of 1.85 after 11 am.

That is our 3rd massive double digit runner in a row.

We have another bounce profile for you to take a look at.

This one has a similar chart to the others in that it has recently taken a bit of a dip.

Pull up ATLX right away and start your research.

Focused on moving from exploration to profitability; Atlas Lithium Corporation (NASDAQ: ATLX) is a U.S.-based mineral exploration company with the largest size and breadth of exploration projects for strategic minerals in Brazil, a premier mineral jurisdiction.

ATLX intends to be a leader in the provisioning of minerals essential to the transformation of the global economy from fossil fuels to electrification, a process which is expected to take decades.

The company’s properties encompass approximately 539 km2 for lithium, as well as mineral rights for nickel, rare earths, titanium and graphite. Atlas Lithium also owns 32% of Atlas Critical Minerals Corporation.

Company Highlights

Over the last several years, Atlas Lithium has assembled Brazil’s largest portfolio of lithium mineral rights among publicly listed companies.

ATLX holds three key projects that span the major lithium-mineralized zones in LV:

1. The Neves Project in southern LV, Atlas Lithium’s flagship development, which has recently been permitted and is advancing towards production;

2. The Salinas Project in northern LV, spanning 2,070 acres with natural spodumene outcrops, and is located 4.7 miles from Latin Resources Ltd., and with potential for spodumene deposits;

3. The Clear Project in central LV, which encompasses 470 acres, is situated 3.8 miles from Sigma Lithium’s (NASDAQ: SGML) Grota do Cirilo mine. There is also potential for spodumene deposits. Sigma Lithium has a market cap of roughly $1.2B! (Note: ATLX’s lithium processing manager James Schloffer had a key role at Sigma!)

State-of-the-Art Processing Plant En Route to Brazil

In a major milestone that accelerates Atlas Lithium’s path to becoming Brazil’s next significant lithium producer, the company’s innovative processing plant is now making its way Brazil. The plant, which departed South Africa on February 2, 2025, is comprised of 141 containers and 10 bulk items, showcasing efficient design features that will set a new industry standard in lithium processing.


The fully-paid plant, valued in tens of millions of dollars, reaffirms Atlas Lithium’s commitment to sustainable mining practices while positioning the company at the forefront of the global lithium industry. With its water-smart technology and eco-friendly low physical footprint, the facility is set to become Brazil’s first modular DMS plant, demonstrating Atlas Lithium’s leadership in responsible resource development.


The plant’s arrival at Brazil’s Port of Santos is scheduled for March 2, 2025. This innovative facility will enable Atlas Lithium to deliver premium-quality lithium concentrate to the rapidly growing electric vehicle and renewable energy markets, reinforcing the company’s position as an emerging leader in sustainable lithium production.

Strategic Partnership with Global Industrial Giant

In a transformative development, Atlas Lithium secured a strategic partnership with Mitsui & Co., Ltd., one of Japan’s largest global trading and investment companies with operations in over 60 countries. In March 2024, Mitsui demonstrated its confidence in Atlas Lithium’s potential by making a substantial US$30 million strategic investment at a 10% premium to market price. The partnership includes a significant offtake agreement lithium concentrate from Atlas Lithium’s Neves Project. Notably, Mitsui’s largest shareholder is Warren Buffett’s Berkshire Hathaway, adding another layer of institutional validation to Atlas Lithium’s business model.

‍

Within the global lithium industry, Brazil’s LV has emerged as a premier hard-rock lithium jurisdiction.

Brazil’s advantages include year-round mining operations, lower labor costs, and a supportive government. The country’s lithium industry outperforms Australian producers on costs; Pilbara Mineral’s US$370M acquisition of a Brazilian lithium explorer in August 2024 highlights the region’s importance.


“Investments in lithium production in Minas Gerais are projected to range from $3.9 billion to $5.8 billion by 2030,” according to João Paulo Braga, CEO of the state investment promotion agency, Invest Minas.

Few countries besides Brazil have such an advantageous position to attract investment, as other Latin American nations face uncertainties and political risks.

ATLX’s Minas Gerais Lithium Project is its largest endeavor and consists of 85 mineral rights totaling approximately 468 km2 which include seven main clusters of prospective mineralization: Neves (currently being explored by drilling campaign and referred to as the “Neves Project”), Coronel Murta, Eastern Properties, Itinga, Salinas, Santa Clara, and Tesouras.

Several of the company’s mineral rights are located adjacent to or near mineral rights that belong to a large publicly traded competitor company which has demonstrated through extensive drilling the presence of lithium deposits totaling over 100 million tons, according to its publicly available filings!

This is a Highly Attractive Location:

◼ Resource Potential to Support Large Scale Operations
✓ The Brazilian Geological Service (CPRM) suggested that the region has at least 45 lithium deposits
✓ Adjacent to operational lithium mines in the region such as Sigma Lithium and CBL

◼ Licensing Fast Track to Speed up Project Execution – Atlas with Permits in Place
✓ Minas Gerais government created a fast-track process, under the InvestMinas Program, to facilitate project development and allow for licensing to be issued quickly
✓ Mining friendly jurisdiction: 300+ operating mines in the state of Minas Gerais

◼ Favorable Infrastructure
✓ Access to abundant renewable & clean energy sources and highway roads directly connected to intercontinental ports to supply main markets

Recent exploration activities at both the company’s Salinas and the Clear Projects have yielded significant progress, and such development bodes well for ATLX’s strategy of securing as many high-quality deposit areas within LV as feasible.

A Big Neighbor

Atlas Lithium’s strategic holdings of 85 mineral rights across 468 km2 in Minas Gerais position it as the emerging force in Brazil’s Lithium Valley, with several properties adjacent to Sigma Lithium Corporation, the region’s established producer. Sigma’s current market capitalization of approximately $1.2 billion—approximately twelve times that of Atlas Lithium—demonstrates the extraordinary value potential in the region. As Atlas Lithium follows a similar development path in the same proven lithium district the company represents a compelling growth opportunity at its current market valuation. The success of Sigma Lithium in establishing large-scale lithium operations provides a clear blueprint for Atlas Lithium’s development trajectory in this world-class mining jurisdiction.

Atlas Lithium’s Plant Is Now En Route to Brazil – Marking Major Milestone Towards Production

Boca Raton, Florida–(Newsfile Corp. – February 3, 2025) – Atlas Lithium Corporation(NASDAQ: ATLX) (“Atlas Lithium” or the “Company”) is pleased to announce the successful shipment of its modular dense media separation (DMS) lithium processing plant from South Africa to Brazil. This milestone marks a significant step in the Company’s progression toward becoming the next lithium producer in Brazil’s resource-rich Lithium Valley.

Atlas Lithium’s DMS plant represents a cornerstone of the Company’s Neves Project, designed to deliver high-quality lithium concentrate to the global market for electric vehicles (EVs) and renewable energy storage systems. With worldwide lithium demand growing, Atlas Lithium is positioned to emerge as a key contributor to the sustainable energy transition.

The shipment, consisting of 141 containers and 10 bulk items, departed the Port of Durban, South Africa, on February 2, 2025, aboard the cargo vessel Irene’s Wisdom (IMO: 9953391), marking the culmination of months of meticulous planning and preparation. The newly manufactured processing facility, fully paid for and owned by Atlas Lithium, is scheduled to arrive at the Port of Santos, Brazil, on March 2, 2025.

Atlas Lithium’s CFO, Tiago Miranda, and Logistics Coordinator, Graciela Vieira, personally inspected the shipment prior to its departure from South Africa, ensuring components were securely packaged for the oceanic journey. Some remaining items of the plant, all of them spare parts, will be shipped to Brazil in two additional containers in March, 2025.

“The news announced today is transformational for Atlas Lithium as our fully paid processing plant significantly reduces project risk,” said Eduardo Queiroz, Atlas Lithium’s Project Management Officer (PMO) and Vice President of Engineering. “Our momentum is clear: from securing our operational permit in October, 2024, to completing fabrication of our optimized DMS plant in South Africa, and now executing its careful shipment to Brazil, Atlas Lithium has firmly delivered several critical milestones.”

Innovative Features of the DMS Plant

The modular DMS plant incorporates cutting-edge and environmentally conscious design, setting a new benchmark for lithium processing:

• Compact, Modular Design: Enables efficient transportation and installation.
• Reduced Environmental Footprint: Optimized physical footprint minimizes environmental impact while ensuring high operational efficiency.
• Advanced Water Conservation: Internal recycling systems drastically reduce water usage.
• Sustainable Tailings Management: Dry-stacking technology eliminates the need for tailings dams, enhancing environmental sustainability.

Strategic Progress Toward Production

The Company believes that its operations in Brazil’s Lithium Valley will benefit from significant strategic advantages, including competitive production costs and high-quality spodumene. Atlas Lithium is well-positioned to meet robust demand for premium-grade lithium concentrate, particularly from Asian markets where electric vehicle adoption continues to accelerate.

‍

NEWS

Atlas Lithium to Present at Fastmarkets Battery Raw Materials Shanghai 2025 Conference

Feb 10, 2025

Atlas Lithium’s Plant Is Now En Route to Brazil – Marking Major Milestone Towards Production

Feb 3, 2025

Atlas Lithium’s Processing Plant Prepares for Shipment to Brazil

Jan 21, 2025

Atlas Lithium Accelerates Production Readiness with Key Executive Appointments

Dec 30, 2024

Atlas Lithium Outlines Regional Growth Strategy

Nov 25, 2024

Atlas Lithium’s Neves Project Is Now Permitted

Oct 28, 2024

Atlas Lithium Advances Its Salinas Project

Oct 7, 2024

Atlas Lithium Progresses Towards Key Permitting

Sep 23, 2024

Atlas Lithium’s Progress: Processing Plant Readies For Shipment To Site

Aug 28, 2024

Atlas Lithium Recognized for Its Plant Design

Aug 27, 2024

Atlas Lithium’s Modular Lithium Processing Plant Readies for Brazil

Aug 22, 2024

All Eyes On Atlas Lithium As The US Assistant Secretary Of State For Energy Resources Visits The Company’s Headquarters In Brazil

Jul 26, 2024

Atlas Lithium Strengthens Position In Global Market With Brazilian Mineral Rights Expansion

Jun 24, 2024

Atlas Lithium Doubles the Size of Its Lithium Exploration Footprint in Brazil; Provides Exploration Update

Jun 17, 2024

Atlas Lithium to Co-host the Inaugural Brazil Lithium Summit

Jun 3, 2024

Atlas Lithium (NASDAQ: ATLX) Positions Itself To Meet Soaring Global Lithium Demand With Strategic Investments From Global Partners

May 30, 2024

Atlas Lithium (NASDAQ: ATLX) Reaches Final Fabrication And Trial Assembly Stage For Its Modular Lithium Processing Plant

May 14, 2024

Atlas Lithium’s Modular Processing Plant Enters Final Fabrication and Trial Assembly Stage

May 7, 2024

Atlas Lithium (NASDAQ: ATLX) Secures Partnerships With Suppliers To Tesla, BYD And Secures Funding From Mitsui & Co. To Fuel Growth

Apr 12, 2024

Atlas Lithium (NASDAQ: ATLX) Secures Game-Changing $30,000,000 Strategic Investment From Mitsui & Co.

Apr 2, 2024

MANAGEMENT

Marc Fogassa

Chairman & Chief Executive Officer

Marc Fogassa has been a director and our Chairman and Chief Executive Officer since 2012. He has extensive experience in venture capital and public company chief executive management. He has served on boards of directors of multiple private companies in various industries and has been invited to speak about investment issues, particularly as related to Brazil. Mr. Fogassa double majored at the Massachusetts Institute of Technology (M.I.T.), graduating with two Bachelor of Science degrees in 1990. He later graduated from the Harvard Medical School with a Doctor of Medicine degree in 1995 and also from the Harvard Business School with a Master of Business Administration degree in 1999 with Second-Year Honors. At Harvard Business School, he was Co-President of the Venture Capital and Private Equity Club. Mr. Fogassa was born in Brazil and is fluent in Portuguese and English. Mr. Fogassa is also the Chairman and Chief Executive Officer of Jupiter Gold Corporation and Chairman and Chief Executive Officer of Apollo Resources Corporation, two companies in which we own equity positions.

Tiago Miranda

CFO & Treasurer

Tiago Miranda is our Chief Financial Officer, Principal Accounting Officer, and Treasurer. From February 2024 until July 2024, Mr. Miranda was the Chief Financial Officer of Apollo Resources Corporation, a private company and a subsidiary of Atlas Lithium. In such capacity, Mr. Miranda managed all of Apollo Resources’ financial and administrative related processes, including treasury, accounting, tax, and financial planning and budgeting.

Previously, from May 2020 to December 2023, Mr. Miranda was the senior financial officer for the Brazilian operations of Horizonte Minerals Plc., a British publicly listed company with two nickel projects in Brazil. During his tenure, he successfully contributed to securing project financing of US$713 million for a ferronickel project and an additional $300 million Brazilian real credit facility with Banco da Amazônia. Between November 2019 to April 2020, Mr. Miranda held the position of Financial Controller for the Brazilian operations at Equinox Gold, a Canadian publicly listed gold producer.

From March 2008 to October 2019, Mr. Miranda served as the Controller of Ferrous Resources Ltd., an iron producer partially owned by Icahn Enterprises, a NYSE-listed company. He actively contributed to the development of company projects from exploration through construction and operation and was also heavily involved in Ferrous Resources’ US$550 million sale to Vale S/A, the largest Brazilian mining company.

From September 2005 to March 2008, Mr. Miranda was an auditor with Deloitte Touche Tohmatsu in Brazil. He has an undergraduate degree in Business Administration and Accounting, and a Master of Business Administration, both from IBMEC in Brazil. Mr. Miranda is fluent in Portuguese and English.

Eduardo Queiroz

Project Management Officer (PMO) & Vice President of Engineering

Eduardo Queiroz has served as Project Management Officer and Vice President of Engineering at Atlas Lithium since December 2024. He brings over 20 years of expertise in managing large-scale and complex mining projects, most recently as General Manager of Planning and Management at Bamin, a unit of Eurasian Resources Group. During his tenure at Bamin, he successfully led the strategic planning of several projects exceeding US$3 billion in value, including an integrated iron ore mining project that encompassed mining operations, processing plant, railway, and ocean port facilities.

Mr. Queiroz’s comprehensive experience includes engineering oversight, environmental compliance, risk management, and the implementation of cost-efficient operational strategies. His expertise in project implementation and management of Brazilian mining projects makes him instrumental in driving Atlas Lithium’s Neves Project toward revenue generation. He holds an MBA in Project Management from Fundação Getúlio Vargas and a degree in Civil Engineering from the Universidade Federal de Ouro Preto.

Igor Tkachenko

Vice President, Corporate Strategy

Igor Tkachenko has been our Vice President of Corporate Strategy since 2023. Igor Tkachenko, a Ukrainian-American and a US-trained physician, has served as a strategic advisor to us since 2021, lending his leadership talents and private sector experience to further the company’s mission to become a leading hard-rock lithium provider for the green energy transition. In 2022, Mr. Tkachenko began consulting for us as our Director of Strategic Development, overseeing the rapid expansion of our investor relations efforts. He participated in the design and execution of our organizational growth strategy that led to our successful up-listing to Nasdaq in January 2023. On the heels of this major milestone, Mr. Tkachenko transitioned from his academic role as a Clinical Assistant Professor to take on an executive position at Atlas Lithium and began serving as our Vice President of Corporate Strategy in 2023. His education includes a Bachelor of Science (Summa Cum Laude) and a Doctor of Medicine degrees.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SEVEN THOUSAND USD BY SIDEWAYS FREQUENCY LLC FOR A ONE DAY ATLX AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.